The	O
tax	B-protein
protein	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
mediates	O
the	O
transactivation	O
of	O
the	O
c-sis/platelet-derived	B-DNA
growth	I-DNA
factor-B	I-DNA
promoter	I-DNA
through	O
interactions	O
with	O
the	O
zinc	B-protein
finger	I-protein
transcription	I-protein
factors	I-protein
Sp1	B-protein
and	O
NGFI-A/Egr-1	B-protein
.	O

Transcriptional	O
up-regulation	O
of	O
the	O
c-sis/platelet-derived	B-DNA
growth	I-DNA
factor-B	I-DNA
(	I-DNA
PDGF-B	I-DNA
)	I-DNA
proto-oncogene	I-DNA
by	O
the	O
Tax	B-protein
protein	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
has	O
been	O
implicated	O
as	O
one	O
possible	O
mechanism	O
of	O
cellular	O
transformation	O
by	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
.	O

In	O
previous	O
work	O
,	O
we	O
identified	O
an	O
essential	O
site	O
in	O
the	O
c-sis/PDGF-B	B-DNA
promoter	I-DNA
,	O
Tax-responsive	B-DNA
element	I-DNA
1	I-DNA
(	O
TRE1	B-DNA
)	O
,	O
necessary	O
for	O
transactivation	O
by	O
Tax	B-protein
.	O

We	O
also	O
identified	O
Sp1	B-protein
,	O
Sp3	O
,	O
and	O
NGFI-A/Egr-1	B-protein
as	O
the	O
primary	B-protein
nuclear	I-protein
transcription	I-protein
factors	I-protein
binding	O
to	O
TRE1	B-DNA
which	O
mediate	O
Tax	B-protein
responsiveness	O
.	O

In	O
the	O
present	O
work	O
,	O
we	O
have	O
investigated	O
the	O
mechanism	O
(	O
s	O
)	O
whereby	O
Tax	B-protein
transactivates	O
the	O
c-sis/PDGF-B	B-DNA
proto-oncogene	I-DNA
.	O

In	O
vitro	O
transcription	O
assays	O
showed	O
that	O
Tax	B-protein
was	O
able	O
to	O
significantly	O
increase	O
the	O
transcriptional	O
activity	O
of	O
a	O
template	O
containing	O
the	O
-257	B-DNA
to	I-DNA
+74	I-DNA
region	I-DNA
of	O
the	O
c-sis/PDGF-B	B-DNA
promoter	I-DNA
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
analysis	O
showed	O
that	O
Tax	B-protein
increased	O
the	O
DNA	O
binding	O
activity	O
of	O
both	O
Sp1	B-protein
and	O
NGFI-A/Egr-1	B-protein
using	O
a	O
TRE1	B-DNA
probe	I-DNA
.	O

Analysis	O
of	O
Tax	B-protein
mutants	I-protein
showed	O
that	O
two	O
mutants	O
,	O
IEXC29S	B-protein
and	O
IEXL320G	B-protein
,	O
were	O
unable	O
to	O
significantly	O
transactivate	O
the	O
c-sis/PDGF-B	B-DNA
promoter	I-DNA
.	O

Finally	O
,	O
co-immunoprecipitation	O
analysis	O
revealed	O
that	O
Tax	B-protein
is	O
able	O
to	O
stably	O
bind	O
to	O
both	O
Sp1	B-protein
and	O
NGFI-A/Egr-1	B-protein
.	O

Interestingly	O
,	O
co-immunoprecipitation	O
analysis	O
also	O
revealed	O
that	O
Tax	B-protein
mutant	O
IEXC29S	B-protein
is	O
unable	O
to	O
interact	O
with	O
NGFI-A/Egr-1	B-protein
,	O
whereas	O
Tax	B-protein
mutant	O
IEXL320G	B-protein
is	O
able	O
to	O
interact	O
with	O
NGFI-A/Egr-1	B-protein
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

43	NULL
,	NULL
Issue	NULL
of	NULL
October	NULL
24	NULL
,	NULL
pp	NULL
.	NULL

27411-27421	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
Tax	NULL
Protein	NULL
of	NULL
Human	NULL
T-cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
Mediates	NULL
the	NULL
Transactivation	NULL
of	NULL
the	NULL
c-sis/Platelet-derived	NULL
Growth	NULL
Factor-B	NULL
Promoter	NULL
through	NULL
Interactions	NULL
with	NULL
the	NULL
Zinc	NULL
Finger	NULL
Transcription	NULL
Factors	NULL
Spl	NULL
and	NULL
NGFI-A/Egr-1	NULL
*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
February	NULL
19	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
August	NULL
11	NULL
,	NULL
1997	NULL
)	NULL
Samuel	NULL
R.	NULL
Trejo	NULL
$	NULL
,	NULL
William	NULL
E.	NULL
Fahl§	NULL
,	NULL
and	NULL
Lee	NULL
Ratner	NULL
?	NULL

!	NULL

From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
and	NULL
the	NULL
§McArdle	NULL
Laboratory	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
University	NULL
of	NULL
Wisconsin	NULL
Medical	NULL
School	NULL
,	NULL
Madison	NULL
,	NULL
Wisconsin	NULL
53706	NULL
Transcriptional	NULL
up-regulation	NULL
of	NULL
the	NULL
c-sis/platelet-derived	NULL
growth	NULL
factor-B	NULL
(	NULL
PDGF-B	NULL
)	NULL
proto-oncogene	NULL
by	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
one	NULL
possible	NULL
mechanism	NULL
of	NULL
cellular	NULL
transformation	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

In	NULL
previous	NULL
work	NULL
,	NULL
we	NULL
identified	NULL
an	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
c-sis	NULL
[	NULL
PDGF-B	NULL
promoter	NULL
,	NULL
Tax-responsive	NULL
element	NULL
1	NULL
(	NULL
TRE1	NULL
)	NULL
,	NULL
necessary	NULL
for	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL

We	NULL
also	NULL
identified	NULL
Spl	NULL
,	NULL
Sp3	NULL
,	NULL
and	NULL
NGFI-A/Egr-1	NULL
as	NULL
the	NULL
primary	NULL
nuclear	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
TREl	NULL
which	NULL
mediate	NULL
Tax	NULL
responsiveness	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
whereby	NULL
Tax	NULL
transactivates	NULL
the	NULL
c-sis/PDGF-B	NULL
proto-oncogene	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
assays	NULL
showed	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
significantly	NULL
increase	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
template	NULL
containing	NULL
the	NULL
-257	NULL
to	NULL
+74	NULL
region	NULL
of	NULL
the	NULL
c-sis/	NULL
PDGF-B	NULL
promoter	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
analysis	NULL
showed	NULL
that	NULL
Tax	NULL
increased	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
both	NULL
Spl	NULL
and	NULL
NGFI-A/Egr-1	NULL
using	NULL
a	NULL
TRE1l	NULL
probe	NULL
.	NULL

Analysis	NULL
of	NULL
Tax	NULL
mutants	NULL
showed	NULL
that	NULL
two	NULL
mutants	NULL
,	NULL
IEXC29S8	NULL
and	NULL
IEXL320G	NULL
,	NULL
were	NULL
unable	NULL
to	NULL
significantly	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

Finally	NULL
,	NULL
co-immunoprecipitation	NULL
analysis	NULL
revealed	NULL
that	NULL
Tax	NULL
is	NULL
able	NULL
to	NULL
stably	NULL
bind	NULL
to	NULL
both	NULL
Spl	NULL
and	NULL
NGFI-A/Egr-1	NULL
.	NULL

Interestingly	NULL
,	NULL
co-immunoprecipitation	NULL
analysis	NULL
also	NULL
revealed	NULL
that	NULL
Tax	NULL
mutant	NULL
IEXC29S8	NULL
is	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
NGFT-A/Egr-1	NULL
,	NULL
whereas	NULL
Tax	NULL
mutant	NULL
IEXL320G	NULL
is	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
NGFT-A/Egr-1	NULL
.	NULL

Infection	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
'	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
highly	NULL
aggressive	NULL
and	NULL
fatal	NULL
malignancy	NULL
of	NULL
mature	NULL
and	NULL
T-helper	NULL
lymphocytes	NULL
,	NULL
adult	NULL
T-cell	NULL
leukemia/lym-phoma	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
degenerative	NULL
neuromuscular	NULL
disease	NULL
,	NULL
trop-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
CA63417	NULL
(	NULL
to	NULL
L.	NULL
R.	NULL
)	NULL
and	NULL
Molecular	NULL
Hematology	NULL
Training	NULL
Grant	NULL
5	NULL
T32	NULL
HLO7088	NULL
(	NULL
to	NULL
S.	NULL
R.	NULL
T.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

1	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Div	NULL
.	NULL

of	NULL
Molecular	NULL
Oncology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
S.	NULL
Euclid	NULL
,	NULL
Box	NULL
8069	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
314-862-8886	NULL
;	NULL
Fax	NULL
:	NULL
314-747-2797	NULL
;	NULL
E-mail	NULL
:	NULL
Iratner	NULL
@	NULL
imgate.wustl.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
HTLV-1	NULL
,	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
;	NULL
TRE	NULL
,	NULL
Tax	NULL
responsive	NULL
element	NULL
;	NULL
PDGF	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-18-acetate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
CREB/	NULL
ATF	NULL
,	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
proteins/activating	NULL
transcription	NULL
factor	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
PMSF	NULL
,	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
;	NULL
pol	NULL
II	NULL
,	NULL
polymerase	NULL
II	NULL
;	NULL
PTHrP	NULL
,	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
;	NULL
bZIP	NULL
,	NULL
basic	NULL
region-leucine	NULL
zipper	NULL
;	NULL
NGFI-A	NULL
,	NULL
nerve	NULL
growth	NULL
factor	NULL
I	NULL
A	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
ical	NULL
spastic	NULL
paraparesis/HTLV-1	NULL
associated	NULL
myelopathy	NULL
,	NULL
in	NULL
humans	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Replication	NULL
of	NULL
the	NULL
virus	NULL
is	NULL
strongly	NULL
dependent	NULL
upon	NULL
expression	NULL
of	NULL
the	NULL
virally	NULL
encoded	NULL
Tax	NULL
protein	NULL
,	NULL
a	NULL
potent	NULL
trans-activator	NULL
of	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
4-8	NULL
)	NULL
.	NULL

Tax	NULL
is	NULL
highly	NULL
pleiotropic	NULL
,	NULL
as	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
transcriptionally	NULL
activate	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
IL-2	NULL
(	NULL
9	NULL
)	NULL
,	NULL
IL-2Ra	NULL
(	NULL
9	NULL
)	NULL
,	NULL
granulocyte	NULL
macrophage/colony-stimulating	NULL
factor	NULL
(	NULL
9	NULL
)	NULL
,	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
(	NULL
9	NULL
)	NULL
,	NULL
c-fos	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
e-sis	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Tax	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
but	NULL
appears	NULL
to	NULL
stimulate	NULL
RNA	NULL
synthesis	NULL
mediated	NULL
through	NULL
several	NULL
structurally	NULL
unrelated	NULL
cellular	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
.	NULL

These	NULL
include	NULL
members	NULL
of	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
proteins	NULL
and	NULL
activating	NULL
transcription	NULL
factor	NULL
(	NULL
CREB/ATF	NULL
)	NULL
family	NULL
,	NULL
serum	NULL
response	NULL
factor	NULL
,	NULL
Fos-Jun	NULL
,	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
of	NULL
transcription	NULL
regulatory	NULL
proteins	NULL
(	NULL
13-20	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
only	NULL
a	NULL
single	NULL
gene	NULL
,	NULL
the	NULL
B-polymerase	NULL
gene	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
repressed	NULL
by	NULL
Tax	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
c-sis	NULL
proto-oncogene	NULL
,	NULL
which	NULL
encodes	NULL
the	NULL
B-chain	NULL
of	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
(	NULL
PDGF	NULL
)	NULL
(	NULL
283	NULL
,	NULL
24	NULL
)	NULL
,	NULL
is	NULL
actively	NULL
transcribed	NULL
in	NULL
T-cells	NULL
infected	NULL
with	NULL
HTLV-1	NULL
.	NULL

The	NULL
transcript	NULL
has	NULL
been	NULL
cloned	NULL
and	NULL
sequenced	NULL
,	NULL
and	NULL
is	NULL
apparently	NULL
normal	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
c-sis	NULL
is	NULL
normally	NULL
tightly	NULL
regulated	NULL
in	NULL
a	NULL
cell	NULL
type-and	NULL
developmental	NULL
stage-specific	NULL
manner	NULL
and	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
wound	NULL
healing	NULL
and	NULL
early	NULL
development	NULL
(	NULL
28	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
normally	NULL
expressed	NULL
,	NULL
however	NULL
,	NULL
in	NULL
lymphocytes	NULL
.	NULL

PDGF	NULL
is	NULL
a	NULL
potent	NULL
mitogen	NULL
and	NULL
chemoattractant	NULL
for	NULL
cells	NULL
of	NULL
mesenchymal	NULL
origin	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Biologically	NULL
active	NULL
PDGF	NULL
is	NULL
a	NULL
dimeric	NULL
protein	NULL
consisting	NULL
of	NULL
homo-	NULL
and	NULL
heterodimeric	NULL
combinations	NULL
of	NULL
two	NULL
polypeptide	NULL
chains	NULL
,	NULL
A	NULL
and	NULL
B	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
major	NULL
function	NULL
of	NULL
PDGF	NULL
is	NULL
to	NULL
induce	NULL
mitosis	NULL
in	NULL
quiescent	NULL
target	NULL
cells	NULL
.	NULL

PDGF	NULL
exerts	NULL
its	NULL
effects	NULL
through	NULL
binding	NULL
to	NULL
two	NULL
types	NULL
of	NULL
receptors	NULL
,	NULL
the	NULL
a	NULL
receptor	NULL
,	NULL
which	NULL
binds	NULL
both	NULL
A	NULL
and	NULL
B	NULL
chains	NULL
with	NULL
high	NULL
affinity	NULL
,	NULL
and	NULL
the	NULL
B	NULL
receptor	NULL
,	NULL
which	NULL
binds	NULL
only	NULL
the	NULL
B	NULL
chain	NULL
(	NULL
31	NULL
)	NULL
.	NULL

PDGF	NULL
was	NULL
first	NULL
implicated	NULL
in	NULL
the	NULL
process	NULL
of	NULL
transformation	NULL
when	NULL
one	NULL
of	NULL
its	NULL
polypeptide	NULL
chains	NULL
,	NULL
the	NULL
B-chain/c-sis	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
homolo-gous	NULL
to	NULL
the	NULL
viral	NULL
sis	NULL
oncogene	NULL
(	NULL
v-sis	NULL
)	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
expression	NULL
of	NULL
a	NULL
recombinant	NULL
,	NULL
wild-type	NULL
human	NULL
c-sis/PDGF-B	NULL
gene	NULL
in	NULL
mouse	NULL
3T3	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
both	NULL
the	NULL
a	NULL
and	NULL
B	NULL
PDGF	NULL
receptors	NULL
,	NULL
resulted	NULL
in	NULL
the	NULL
transformation	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Because	NULL
lymphocytes	NULL
in	NULL
general	NULL
were	NULL
thought	NULL
to	NULL
have	NULL
no	NULL
receptors	NULL
for	NULL
PDGF	NULL
,	NULL
it	NULL
was	NULL
previously	NULL
postulated	NULL
that	NULL
the	NULL
c-sis/	NULL
PDGF-B	NULL
expression	NULL
in	NULL
HTLV-1	NULL
infected	NULL
T-cells	NULL
could	NULL
possibly	NULL
provide	NULL
a	NULL
paracrine	NULL
function	NULL
,	NULL
perhaps	NULL
stimulating	NULL
stromal	NULL
cells	NULL
,	NULL
or	NULL
other	NULL
nonlymphocytic	NULL
cells	NULL
known	NULL
to	NULL
have	NULL
PDGF	NULL
re-ceptors	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
however	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
HTLV-1	NULL
infected	NULL
T-cells	NULL
also	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
PDGF-B	NULL
receptor	NULL
transcripts	NULL
and	NULL
synthesize	NULL
protein	NULL
that	NULL
can	NULL
be	NULL
immunoprecipitated	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
PDGF	NULL
receptor	NULL
that	NULL
binds	NULL
the	NULL
PDGF-B	NULL
homodimer	NULL
and	NULL
the	NULL
PDGF-AB	NULL
het-	NULL
27411	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27412	NULL
erodimer	NULL
(	NULL
83	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
the	NULL
possibility	NULL
that	NULL
HTLV-1	NULL
infected	NULL
T-cells	NULL
might	NULL
acquire	NULL
an	NULL
auotcrine	NULL
mechanism	NULL
of	NULL
cell	NULL
proliferation	NULL
that	NULL
involves	NULL
PDGF	NULL
.	NULL

With	NULL
regard	NULL
to	NULL
the	NULL
regulatory	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
that	NULL
underlies	NULL
c-sis/PDGF-B	NULL
expression	NULL
in	NULL
HTLV-1-infected	NULL
T-cells	NULL
,	NULL
previous	NULL
work	NULL
from	NULL
our	NULL
laboratory	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
others	NULL
(	NULL
35-39	NULL
)	NULL
,	NULL
identified	NULL
a	NULL
regulatory	NULL
site	NULL
at	NULL
-64	NULL
to	NULL
-45	NULL
within	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
,	NULL
that	NULL
we	NULL
named	NULL
Tax-responsive	NULL
element	NULL
1	NULL
(	NULL
TRE1	NULL
)	NULL
.	NULL

This	NULL
regulatory	NULL
site	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
analysis	NULL
and	NULL
antibody	NULL
supershift	NULL
analysis	NULL
of	NULL
TRE1-binding	NULL
proteins	NULL
in	NULL
Jurkat-E6.1	NULL
and	NULL
Jurkat-Tax	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
along	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
HTLV-1	NULL
infected	NULL
T-cell	NULL
line	NULL
,	NULL
HUT1O2	NULL
,	NULL
identified	NULL
the	NULL
Sp	NULL
family	NULL
members	NULL
,	NULL
Spl	NULL
and	NULL
Sp3	NULL
,	NULL
along	NULL
with	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
response	NULL
gene	NULL
family	NULL
,	NULL
NGFI-A/Egr-1	NULL
(	NULL
for	NULL
the	NULL
sake	NULL
of	NULL
simplicity	NULL
,	NULL
NGFT-A/Egr-1	NULL
from	NULL
this	NULL
point	NULL
on	NULL
will	NULL
be	NULL
referred	NULL
to	NULL
as	NULL
Egr-1	NULL
)	NULL
,	NULL
as	NULL
the	NULL
main	NULL
TRE1-binding	NULL
factors	NULL
mediating	NULL
Tax-responsiveness	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
whereby	NULL
Tax	NULL
transactivates	NULL
the	NULL
c-sis/PDGF-B	NULL
proto-oncogene	NULL
promoter	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
analysis	NULL
showed	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
markedly	NULL
increase	NULL
RNA	NULL
synthesis	NULL
from	NULL
a	NULL
template	NULL
containing	NULL
the	NULL
-257	NULL
to	NULL
+74	NULL
region	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
TRE1	NULL
region	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
a	NULL
CCACCC	NULL
and	NULL
GNGNGGGNG	NULL
motif	NULL
essential	NULL
for	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL

EMSA	NULL
analysis	NULL
hinted	NULL
at	NULL
a	NULL
possible	NULL
mechanism	NULL
of	NULL
Tax	NULL
transactivation	NULL
in	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
substantially	NULL
increase	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
to	NULL
their	NULL
DNA	NULL
recognition	NULL
sites	NULL
contained	NULL
within	NULL
TRE1	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
EMSA	NULL
analysis	NULL
also	NULL
indicated	NULL
the	NULL
possibility	NULL
of	NULL
ternary	NULL
complex	NULL
formation	NULL
consisting	NULL
of	NULL
Spl	NULL
or	NULL
Egr-1	NULL
,	NULL
Tax	NULL
,	NULL
and	NULL
DNA	NULL
,	NULL
suggesting	NULL
that	NULL
Tax	NULL
might	NULL
stably	NULL
interact	NULL
with	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
through	NULL
protein-protein	NULL
contacts	NULL
.	NULL

We	NULL
show	NULL
by	NULL
co-immunoprecipitation	NULL
analysis	NULL
that	NULL
Tax	NULL
does	NULL
indeed	NULL
stably	NULL
interact	NULL
with	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
in	NULL
both	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
and	NULL
from	NULL
intact	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
identified	NULL
two	NULL
Tax	NULL
mutants	NULL
,	NULL
C298	NULL
and	NULL
L320G	NULL
,	NULL
that	NULL
were	NULL
unable	NULL
to	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
by	NULL
more	NULL
than	NULL
2-fold	NULL
.	NULL

Interestingly	NULL
,	NULL
co-immunoprecipitation	NULL
analysis	NULL
also	NULL
revealed	NULL
that	NULL
Tax	NULL
mutant	NULL
C298	NULL
was	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
Egr-1	NULL
,	NULL
whereas	NULL
,	NULL
Tax	NULL
mutant	NULL
L320G	NULL
was	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
Egr-1	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
article	NULL
support	NULL
the	NULL
possibility	NULL
of	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
additional	NULL
,	NULL
as	NULL
yet	NULL
uncharacterized	NULL
,	NULL
pathway	NULL
of	NULL
transactivation	NULL
by	NULL
Tax	NULL
involving	NULL
members	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-The	NULL
T-cell	NULL
lines	NULL
,	NULL
Jurkat	NULL
E6.1	NULL
and	NULL
Jurkat-Tax	NULL
(	NULL
J-tax-19	NULL
;	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Warner	NULL
C.	NULL
Greene	NULL
)	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
the	NULL
HTLV-1	NULL
infected	NULL
T-cell	NULL
line	NULL
,	NULL
MT2	NULL
,	NULL
were	NULL
grown	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
100	NULL
units	NULL
of	NULL
penicillin/ml	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
streptomycin/ml	NULL
.	NULL

COS-7	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
110	NULL
ug/ml	NULL
sodium	NULL
pyruvate	NULL
,	NULL
100	NULL
units	NULL
of	NULL
penicillin/ml	NULL
,	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
streptomycin/ml	NULL
.	NULL

Stimulation	NULL
of	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
treatment	NULL
for	NULL
6-8	NULL
h	NULL
(	NULL
unless	NULL
otherwise	NULL
specified	NULL
)	NULL
with	NULL
12-O-tetradecanoylphorbol-18-acetate	NULL
(	NULL
TPA	NULL
)	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
0.4	NULL
ug/ml	NULL
)	NULL
.	NULL

Plasmids-The	NULL
c-sis/PDGF-B	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
pRALuc	NULL
,	NULL
the	NULL
pRALue	NULL
linker-scanning	NULL
mutants	NULL
,	NULL
-64/-55	NULL
,	NULL
-54/-45	NULL
,	NULL
and	NULL
-84/	NULL
-25	NULL
and	NULL
the	NULL
pRALue	NULL
site-directed	NULL
mutant	NULL
constructs	NULL
,	NULL
YLO-YL7	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
88	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
Tax	NULL
expression	NULL
plasmid	NULL
IEX	NULL
,	NULL
and	NULL
the	NULL
Tax	NULL
mutant	NULL
expression	NULL
plasmids	NULL
,	NULL
IEXS10A	NULL
(	NULL
serine	NULL
at	NULL
position	NULL
10	NULL
changed	NULL
to	NULL
alanine	NULL
)	NULL
,	NULL
IEXC29S	NULL
(	NULL
cysteine	NULL
at	NULL
position	NULL
29	NULL
changed	NULL
to	NULL
serine	NULL
)	NULL
,	NULL
IEXHA4S8Q	NULL
(	NULL
histidine	NULL
at	NULL
position	NULL
48	NULL
changed	NULL
to	NULL
glu-tamine	NULL
)	NULL
,	NULL
IEXS258A	NULL
(	NULL
serine	NULL
at	NULL
position	NULL
258	NULL
changed	NULL
to	NULL
alanine	NULL
)	NULL
,	NULL
and	NULL
IEXL320G	NULL
(	NULL
leucine	NULL
at	NULL
position	NULL
320	NULL
changed	NULL
to	NULL
glycine	NULL
)	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
NGFI-A/Eigr-1	NULL
expression	NULL
plasmid	NULL
,	NULL
pJDM948	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
pTaxH	NULL
,	NULL
,	NULL
used	NULL
for	NULL
the	NULL
Ni**	NULL
chelate	NULL
chromatography	NULL
purification	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
Tax	NULL
,	NULL
and	NULL
the	NULL
NGFI-A/Egr-1H	NULL
,	NULL
,	NULL
expression	NULL
plasmid	NULL
,	NULL
pJDM1781	NULL
,	NULL
used	NULL
for	NULL
the	NULL
Ni°*	NULL
chelate	NULL
chromatography	NULL
purification	NULL
of	NULL
NGFI-A/Egr-1	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
,	NULL
48	NULL
)	NULL
.	NULL

All	NULL
mutants	NULL
were	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
(	NULL
U.	NULL
S.	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
Luciferase	NULL
Assays-5	NULL
X	NULL
10°	NULL
Jurkat-Tax	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
either	NULL
the	NULL
pRALuc	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
the	NULL
pRALuc	NULL
linker-scanning	NULL
mutants	NULL
,	NULL
-64/-55	NULL
and	NULL
-54/-45	NULL
,	NULL
or	NULL
the	NULL
pRALue	NULL
site-directed	NULL
mutant	NULL
constructs	NULL
,	NULL
YLO-YL7	NULL
,	NULL
using	NULL
the	NULL
Lipofectin	NULL
reagent	NULL
method	NULL
protocol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

When	NULL
stimulated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
equally	NULL
36	NULL
h	NULL
post-transfection	NULL
into	NULL
two	NULL
flasks	NULL
;	NULL
one	NULL
flask	NULL
was	NULL
supplemented	NULL
with	NULL
TPA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
0.4	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
the	NULL
other	NULL
flask	NULL
received	NULL
the	NULL
same	NULL
volume	NULL
of	NULL
solvent	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
an	NULL
ethanol/dry	NULL
ice	NULL
bath	NULL
and	NULL
37	NULL
°C	NULL
water	NULL
bath	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
by	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
used	NULL
for	NULL
the	NULL
luciferase	NULL
assays	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
84	NULL
)	NULL
.	NULL

For	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
Tax	NULL
mutants	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
the	NULL
pRALuc	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
alone	NULL
or	NULL
,	NULL
plus	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
wild-type	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
IEX	NULL
,	NULL
or	NULL
the	NULL
Tax	NULL
mutant	NULL
expression	NULL
plasmids	NULL
,	NULL
IEXS10A	NULL
,	NULL
IEXC29S	NULL
,	NULL
IEXHA43Q	NULL
,	NULL
IEXS258A	NULL
,	NULL
and	NULL
L820G	NULL
,	NULL
using	NULL
the	NULL
Lipofectin	NULL
reagent	NULL
method	NULL
protocol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
post-transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
TPA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
0.4	NULL
ug/ml	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
post-stimulation	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
TPA	NULL
and	NULL
0.4	NULL
ug/ml	NULL
ionomycin	NULL
for	NULL
1-2	NULL
h	NULL
as	NULL
described	NULL
by	NULL
Leiden	NULL
et	NULL
al	NULL
.	NULL

(	NULL
44	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclei	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
for	NULL
2	NULL
min	NULL
following	NULL
cell	NULL
lysis	NULL
with	NULL
40	NULL
mm	NULL
KCl	NULL
,	NULL
10	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
8	NULL
ug	NULL
of	NULL
aprotinin/ml	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
leupeptin/ml	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
v/v	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.42	NULL
M	NULL
KCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
25	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Extracts	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
resulting	NULL
supernatants	NULL
were	NULL
dialyzed	NULL
for	NULL
6-24	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
against	NULL
1	NULL
X	NULL
in	NULL
vitro	NULL
transcription	NULL
buffer	NULL
(	NULL
buffer	NULL
A	NULL
)	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.1	NULL
M	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
20	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
and	NULL
frozen	NULL
in	NULL
aliquots	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Bacterial	NULL
Expression	NULL
and	NULL
Purification	NULL
of	NULL
Recombinant	NULL
TaxH	NULL
,	NULL
and	NULL
Egr-1H	NULL
,	NULL
-Purification	NULL
of	NULL
TaxH	NULL
,	NULL
,	NULL
proceeded	NULL
as	NULL
follows	NULL
:	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
cells	NULL
transformed	NULL
with	NULL
pTaxH	NULL
,	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
1	NULL
liter	NULL
of	NULL
Terrific	NULL
Broth	NULL
medium	NULL
containing	NULL
100	NULL
ug/ml	NULL
ampicillin	NULL
until	NULL
Asoo	NULL
=	NULL
1.0-1.5	NULL
,	NULL
then	NULL
induced	NULL
for	NULL
TaxH	NULL
,	NULL
expression	NULL
with	NULL
40	NULL
uM	NULL
isopro-pyl-1-thio-6-D-galactopyranoside	NULL
at	NULL
room	NULL
temperature	NULL
overnight	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
containing	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
0.25	NULL
mm	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
imidazole	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
ruptured	NULL
by	NULL
sonication	NULL
carried	NULL
out	NULL
at	NULL
a	NULL
60	NULL
%	NULL
duty	NULL
cycle	NULL
for	NULL
4	NULL
X	NULL
1	NULL
min	NULL
duty	NULL
cycle	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
16,000	NULL
X	NULL
g	NULL
for	NULL
80	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
mixed	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
Ni	NULL
``	NULL
*-NTA-agarose	NULL
(	NULL
Qiagen	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h.	NULL
The	NULL
protein	NULL
bound	NULL
gel	NULL
matrix	NULL
was	NULL
then	NULL
packed	NULL
into	NULL
a	NULL
column	NULL
(	NULL
1.5	NULL
em	NULL
X	NULL
10	NULL
cm	NULL
)	NULL
and	NULL
washed	NULL
with	NULL
40	NULL
ml	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
40	NULL
mM	NULL
imidazole	NULL
.	NULL

TaxH	NULL
,	NULL
protein	NULL
was	NULL
then	NULL
eluted	NULL
with	NULL
a	NULL
50-ml	NULL
gradient	NULL
of	NULL
50-500	NULL
mM	NULL
imidazole	NULL
.	NULL

A	NULL
negative	NULL
control	NULL
bacterial	NULL
extract	NULL
(	NULL
prepared	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
from	NULL
bacteria	NULL
that	NULL
were	NULL
transformed	NULL
with	NULL
a	NULL
vector	NULL
containing	NULL
no	NULL
insert	NULL
DNA	NULL
)	NULL
was	NULL
also	NULL
prepared	NULL
.	NULL

Purification	NULL
of	NULL
NGFI-A/Fgr-1H	NULL
,	NULL
,	NULL
proceeded	NULL
as	NULL
follows	NULL
:	NULL
E.	NULL
coli	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
pLysS	NULL
cells	NULL
transformed	NULL
with	NULL
pJDM1731	NULL
were	NULL
grown	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
1	NULL
liter	NULL
of	NULL
Terrific	NULL
Broth	NULL
medium	NULL
containing	NULL
100	NULL
ug/ml	NULL
ampicillin	NULL
and	NULL
60	NULL
pg/liter	NULL
chloramphenicol	NULL
until	NULL
Ago	NULL
,	NULL
=	NULL
0.7-1.0	NULL
,	NULL
then	NULL
induced	NULL
for	NULL
NGFTI-A/Egr-1H	NULL
,	NULL
,	NULL
expression	NULL
with	NULL
800	NULL
pM	NULL
isopropyl-1-thio-B-Dgalac-topyranoside	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
5	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
20	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
containing	NULL
800	NULL
mM	NULL
NaCl	NULL
,	NULL
0.25	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
imidazole	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
ruptured	NULL
by	NULL
sonication	NULL
carried	NULL
out	NULL
at	NULL
a	NULL
60	NULL
%	NULL
duty	NULL
cycle	NULL
for	NULL
4	NULL
X	NULL
1	NULL
min	NULL
duty	NULL
cycle	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
16,000	NULL
X	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
mixed	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
Ni°*-NTA-agarose	NULL
(	NULL
Qiagen	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h.	NULL
The	NULL
protein	NULL
bound	NULL
gel	NULL
matrix	NULL
was	NULL
then	NULL
packed	NULL
into	NULL
a	NULL
column	NULL
(	NULL
1.5	NULL
em	NULL
X	NULL
10	NULL
cm	NULL
)	NULL
and	NULL
washed	NULL
with	NULL
40	NULL
ml	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
40	NULL
mM	NULL
imidazole	NULL
.	NULL

NGFI-A/Fgr-1H	NULL
,	NULL
protein	NULL
was	NULL
then	NULL
eluted	NULL
with	NULL
a	NULL
50-ml	NULL
gradient	NULL
of	NULL
50-500	NULL
mM	NULL
imidazole	NULL
.	NULL

Fractions	NULL
collected	NULL
from	NULL
both	NULL
the	NULL
TaxH	NULL
,	NULL
purification	NULL
and	NULL
the	NULL
NGFT-A/Eigr-1H	NULL
,	NULL
purification	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-7.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
followed	NULL
by	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
staining	NULL
.	NULL

Purity	NULL
of	NULL
each	NULL
was	NULL
determined	NULL
to	NULL
be	NULL
approxi-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
mately	NULL
>	NULL
95	NULL
%	NULL
.	NULL

Fractions	NULL
containing	NULL
purified	NULL
TaxH	NULL
,	NULL
and	NULL
NGFI-A/Figr-1H	NULL
,	NULL
,	NULL
were	NULL
further	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
antisera	NULL
against	NULL
Tax	NULL
(	NULL
@	NULL
TaxC	NULL
;	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
W.	NULL
C.	NULL
Greene	NULL
)	NULL
,	NULL
and	NULL
NGFI-A/Egr-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

The	NULL
fractions	NULL
containing	NULL
either	NULL
purified	NULL
TaxH	NULL
,	NULL
or	NULL
NGFI-A/Eigr-1H	NULL
,	NULL
were	NULL
dialyzed	NULL
for	NULL
6-24	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
against	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.1	NULL
m	NULL
KCl	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
20	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
and	NULL
frozen	NULL
in	NULL
aliquots	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

EMSAs-The	NULL
following	NULL
double-stranded	NULL
oligonucleotide	NULL
probes	NULL
,	NULL
corresponding	NULL
to	NULL
nucleotides	NULL
-83	NULL
to	NULL
-45	NULL
of	NULL
the	NULL
e-sis/PDGF-B	NULL
promoter	NULL
and	NULL
containing	NULL
the	NULL
TRE1	NULL
region	NULL
,	NULL
or	NULL
a	NULL
mutated	NULL
CCACCC	NULL
motif	NULL
of	NULL
the	NULL
TREL	NULL
region	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
prepared	NULL
by	NULL
annealing	NULL
complementary	NULL
,	NULL
sin-gle-stranded	NULL
oligonucleotides	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
in	NULL
a	NULL
thermocycler	NULL
(	NULL
95	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
cool	NULL
to	NULL
25	NULL
°C	NULL
at	NULL
1	NULL
°C/min	NULL
)	NULL
:	NULL
TRE1	NULL
,	NULL
5-GCCAGAAGAG-GAAAGGCTGTCTCCACCCACCTCTCGCAC-3	NULL
'	NULL
;	NULL
TRE1-mSpl	NULL
,	NULL
5'-GC-CAGAAGAGGAAAGGCTGTCTGATCGAACCTCTCGCAC-3	NULL
'	NULL
.	NULL

Each	NULL
probe	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
y-°°P	NULL
]	NULL
ATP	NULL
(	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
.	NULL

Typical	NULL
in	NULL
vitro	NULL
binding	NULL
reactions	NULL
(	NULL
20	NULL
ul	NULL
)	NULL
contained	NULL
approximately	NULL
1	NULL
ng	NULL
of	NULL
either	NULL
purified	NULL
Spl	NULL
(	NULL
Promega	NULL
)	NULL
or	NULL
purified	NULL
NGFI-A/Egr-1H	NULL
,	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Amer-sham	NULL
)	NULL
,	NULL
1	NULL
X	NULL
Superdex	NULL
buffer	NULL
(	NULL
18	NULL
)	NULL
(	NULL
25	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
12.5	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
10	NULL
um	NULL
ZnSO	NULL
,	NULL
150	NULL
mM	NULL
KCl	NULL
,	NULL
4	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
20	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
,	NULL
and	NULL
10-20	NULL
fmol	NULL
of	NULL
*°P-labeled	NULL
probe	NULL
(	NULL
15-80	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
.	NULL

In	NULL
samples	NULL
containing	NULL
TaxH	NULL
,	NULL
,	NULL
,	NULL
approximately	NULL
400	NULL
ng	NULL
of	NULL
purified	NULL
TaxH	NULL
,	NULL
was	NULL
used	NULL
in	NULL
each	NULL
reaction	NULL
.	NULL

EMSA	NULL
analysis	NULL
with	NULL
dilutions	NULL
of	NULL
TaxH	NULL
,	NULL
down	NULL
to	NULL
25	NULL
ng	NULL
was	NULL
also	NULL
performed	NULL
,	NULL
with	NULL
similar	NULL
results	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Once	NULL
all	NULL
of	NULL
the	NULL
appropriate	NULL
factors	NULL
had	NULL
been	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
allowed	NULL
to	NULL
incubate	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
1	NULL
X	NULL
Superdex	NULL
buffer	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
.	NULL

After	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
a	NULL
further	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
then	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
5	NULL
%	NULL
nondenatur-ing	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
acrylamide/N	NULL
,	NULL
NV'-methylenebisacrylamide	NULL
weight	NULL
ratio	NULL
,	NULL
49:1	NULL
)	NULL
at	NULL
165	NULL
V	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
1	NULL
X	NULL
TGE	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.5	NULL
)	NULL
,	NULL
190	NULL
mM	NULL
glycine	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

In	NULL
reactions	NULL
that	NULL
included	NULL
cold	NULL
(	NULL
unlabeled	NULL
)	NULL
oligonucleotide	NULL
competitors	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
allowed	NULL
to	NULL
incubate	NULL
with	NULL
the	NULL
cold	NULL
oligonucleotide	NULL
probes	NULL
,	NULL
along	NULL
with	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
1	NULL
X	NULL
Superdex	NULL
buffer	NULL
,	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
DNA	NULL
probe	NULL
.	NULL

In	NULL
reactions	NULL
containing	NULL
oTaxC	NULL
Ab	NULL
,	NULL
2	NULL
pul	NULL
of	NULL
antiserum	NULL
was	NULL
added	NULL
to	NULL
the	NULL
appropriate	NULL
samples	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
along	NULL
with	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
1	NULL
X	NULL
Superdex	NULL
buffer	NULL
,	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
then	NULL
dried	NULL
under	NULL
vacuum	NULL
at	NULL
80	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
exposed	NULL
to	NULL
XAR-5	NULL
film	NULL
.	NULL

Immunoprecipitation-Co-immunoprecipitation	NULL
reactions	NULL
(	NULL
50	NULL
ul	NULL
)	NULL
,	NULL
using	NULL
purified	NULL
proteins	NULL
,	NULL
contained	NULL
approximately	NULL
200	NULL
ng	NULL
of	NULL
either	NULL
purified	NULL
Spl	NULL
(	NULL
Promega	NULL
)	NULL
or	NULL
purified	NULL
NGFT-A/Egr-1H	NULL
,	NULL
,	NULL
and	NULL
approximately	NULL
400	NULL
ng	NULL
of	NULL
purified	NULL
TaxH	NULL
,	NULL
in	NULL
1	NULL
X	NULL
Superdex	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
,	NULL
containing	NULL
the	NULL
various	NULL
purified	NULL
proteins	NULL
,	NULL
were	NULL
allowed	NULL
to	NULL
incubate	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
5	NULL
pl	NULL
of	NULL
pooled	NULL
Tax	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
a	NULL
Tax	NULL
mAbs	NULL
)	NULL
(	NULL
45	NULL
)	NULL
,	NULL
100	NULL
ul	NULL
of	NULL
5	NULL
X	NULL
Superdex	NULL
buffer	NULL
,	NULL
and	NULL
345	NULL
ul	NULL
of	NULL
dH,0	NULL
.	NULL

For	NULL
co-immunoprecipitation	NULL
reactions	NULL
involving	NULL
HTLV-1-infected	NULL
cells	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
100	NULL
x	NULL
10°	NULL
MT2	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
1	NULL
time	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
PBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
with	NULL
2	NULL
ml	NULL
of	NULL
RIPA	NULL
buffer	NULL
(	NULL
0.5	NULL
%	NULL
deoxycholic	NULL
acid	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
clarified	NULL
by	NULL
spinning	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
divided	NULL
equally	NULL
into	NULL
two	NULL
samples	NULL
;	NULL
to	NULL
one	NULL
sample	NULL
was	NULL
added	NULL
7	NULL
ul	NULL
of	NULL
pooled	NULL
aTax	NULL
mAbs	NULL
,	NULL
the	NULL
other	NULL
sample	NULL
did	NULL
not	NULL
receive	NULL
any	NULL
pooled	NULL
Tax	NULL
mAbs	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
samples	NULL
from	NULL
both	NULL
the	NULL
purified	NULL
protein	NULL
co-immunoprecipitation	NULL
reac-tions	NULL
,	NULL
and	NULL
the	NULL
co-immunoprecipitation	NULL
reactions	NULL
involving	NULL
whole	NULL
cell	NULL
extracts	NULL
prepared	NULL
from	NULL
HTLV-1-infected	NULL
cells	NULL
,	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
on	NULL
a	NULL
rotator	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

50	NULL
ul	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
solution	NULL
of	NULL
immobilized	NULL
rProtein	NULL
A-Sepharose	NULL
(	NULL
Repligen	NULL
Corp.	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
18-24	NULL
h	NULL
on	NULL
a	NULL
rotator	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
then	NULL
gently	NULL
washed	NULL
5-8	NULL
times	NULL
with	NULL
500	NULL
ul	NULL
of	NULL
RIPA	NULL
buffer	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
eluted	NULL
in	NULL
SDS	NULL
sample	NULL
loading	NULL
buffer	NULL
,	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
7.5	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
Western	NULL
blotted	NULL
for	NULL
Tax	NULL
(	NULL
«	NULL
@	NULL
TaxC	NULL
)	NULL
,	NULL
Spl	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
and	NULL
NGFI-A/Fgr-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

After	NULL
each	NULL
individual	NULL
Western	NULL
blot	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
stripped	NULL
by	NULL
submerging	NULL
the	NULL
membrane	NULL
in	NULL
stripping	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
2-mercaptoethanol	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
62.5	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
6.7	NULL
)	NULL
and	NULL
incubating	NULL
at	NULL
50	NULL
°C	NULL
for	NULL
80	NULL
min	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
(	NULL
membrane	NULL
)	NULL
,	NULL
for	NULL
each	NULL
,	NULL
separate	NULL
,	NULL
co-immunoprecipitation	NULL
was	NULL
used	NULL
for	NULL
all	NULL
Western	NULL
blots	NULL
pertaining	NULL
to	NULL
that	NULL
co-immunoprecipitation	NULL
.	NULL

Bands	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
Densitometer	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

27413	NULL
Immunoprecipitation	NULL
Analysis	NULL
of	NULL
Tax	NULL
Mutants	NULL
in	NULL
COS-7	NULL
Cells-5	NULL
ug	NULL
of	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
IEX	NULL
,	NULL
or	NULL
the	NULL
Tax	NULL
mutant	NULL
expression	NULL
plasmids	NULL
,	NULL
IEXC29S	NULL
and	NULL
IEXL820G	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
40-60	NULL
%	NULL
confluent	NULL
COS-7	NULL
cells	NULL
in	NULL
a	NULL
100-mm	NULL
tissue	NULL
culture	NULL
dish	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
Eigr-1	NULL
expression	NULL
plasmid	NULL
,	NULL
pJDM948	NULL
,	NULL
using	NULL
the	NULL
Lipofectin	NULL
reagent	NULL
method	NULL
protocol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

5	NULL
ug	NULL
of	NULL
pJDM948	NULL
was	NULL
also	NULL
transfected	NULL
alone	NULL
into	NULL
40-60	NULL
%	NULL
confluent	NULL
COS-7	NULL
cells	NULL
in	NULL
a	NULL
100-mm	NULL
tissue	NULL
culture	NULL
dish	NULL
as	NULL
a	NULL
control	NULL
for	NULL
Egr-1	NULL
expression	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
transfections	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Forty-eight	NULL
hours	NULL
post-transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
harvested	NULL
by	NULL
trypsinization	NULL
,	NULL
and	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
cells	NULL
from	NULL
all	NULL
samples	NULL
,	NULL
except	NULL
the	NULL
Egr-1	NULL
alone	NULL
sample	NULL
,	NULL
were	NULL
then	NULL
lysed	NULL
by	NULL
resuspending	NULL
the	NULL
cell	NULL
pellet	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
RIPA	NULL
buffer	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
clarified	NULL
by	NULL
spinning	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

For	NULL
the	NULL
Egr-1	NULL
alone	NULL
sample	NULL
,	NULL
a	NULL
whole	NULL
cell	NULL
extract	NULL
was	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
an	NULL
ethanol/dry	NULL
ice	NULL
bath	NULL
and	NULL
37°C	NULL
water	NULL
bath	NULL
.	NULL

5	NULL
ul	NULL
of	NULL
pooled	NULL
Tax	NULL
mAbs	NULL
was	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
,	NULL
except	NULL
the	NULL
Egr-1	NULL
alone	NULL
sample	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
on	NULL
a	NULL
rotator	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

50	NULL
ul	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
solution	NULL
of	NULL
immobilized	NULL
rProtein	NULL
A-Sepharose	NULL
(	NULL
Repligen	NULL
Corp.	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
18-24	NULL
h	NULL
on	NULL
a	NULL
rotator	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
then	NULL
gently	NULL
washed	NULL
5-8	NULL
times	NULL
with	NULL
500	NULL
ul	NULL
of	NULL
RIPA	NULL
buffer	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
eluted	NULL
in	NULL
SDS	NULL
sample	NULL
loading	NULL
buffer	NULL
,	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
7.5	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
Western	NULL
blotted	NULL
for	NULL
Tax	NULL
(	NULL
aTaxC	NULL
)	NULL
and	NULL
Egr-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
by	NULL
ECL	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

After	NULL
each	NULL
Western	NULL
blot	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
stripped	NULL
by	NULL
submerging	NULL
the	NULL
membrane	NULL
in	NULL
stripping	NULL
buffer	NULL
and	NULL
incubating	NULL
at	NULL
50	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
(	NULL
membrane	NULL
)	NULL
was	NULL
used	NULL
for	NULL
both	NULL
Western	NULL
blots	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
Reactions-Typical	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
(	NULL
25	NULL
pul	NULL
)	NULL
contained	NULL
50	NULL
ug	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
E6.1	NULL
nuclear	NULL
extract	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
glass-bead	NULL
purified	NULL
template	NULL
DNA	NULL
(	NULL
the	NULL
954-bp	NULL
Nco	NULL
!	NULL

-EcoRI	NULL
fragments	NULL
of	NULL
either	NULL
pRALuc	NULL
or	NULL
the	NULL
pRALue	NULL
linker-insertion	NULL
mutants	NULL
,	NULL
-64/-55	NULL
,	NULL
-54/-45	NULL
,	NULL
and	NULL
-84/-25	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
400	NULL
uM	NULL
each	NULL
ATP	NULL
,	NULL
CTP	NULL
,	NULL
and	NULL
GTP	NULL
,	NULL
40	NULL
pm	NULL
UTP	NULL
,	NULL
and	NULL
10	NULL
uCi	NULL
of	NULL
(	NULL
8000	NULL
Ci/mmol	NULL
)	NULL
in	NULL
buffer	NULL
A	NULL
.	NULL

Reactions	NULL
involving	NULL
Tax	NULL
contained	NULL
approximately	NULL
400	NULL
ng	NULL
of	NULL
TaxH	NULL
,	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
preincubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
NTPs	NULL
and	NULL
then	NULL
were	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
1	NULL
h	NULL
at	NULL
30	NULL
°C	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
NTPs	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
e-amanitin	NULL
was	NULL
added	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
5	NULL
ug/ml	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
by	NULL
adding	NULL
175	NULL
ul	NULL
of	NULL
stop	NULL
solution	NULL
(	NULL
300	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
300	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
3	NULL
pg/ml	NULL
tRNA	NULL
)	NULL
,	NULL
and	NULL
extracted	NULL
with	NULL
200	NULL
ul	NULL
phenol	NULL
:	NULL
chloroform	NULL
:	NULL
isoamyl	NULL
alcohol	NULL
(	NULL
25:24:1	NULL
)	NULL
.	NULL

Each	NULL
reaction	NULL
was	NULL
then	NULL
passed	NULL
over	NULL
a	NULL
Micro-Spin	NULL
8-300	NULL
HR	NULL
column	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
then	NULL
precipitated	NULL
with	NULL
500	NULL
ul	NULL
of	NULL
100	NULL
%	NULL
ethanol	NULL
,	NULL
placed	NULL
on	NULL
dry	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
pelleted	NULL
,	NULL
washed	NULL
with	NULL
70	NULL
%	NULL
ethanol	NULL
,	NULL
pelleted	NULL
,	NULL
and	NULL
dried	NULL
in	NULL
a	NULL
vacuum	NULL
dessicator	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
loading	NULL
dye	NULL
,	NULL
heated	NULL
at	NULL
90	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
gel	NULL
electrophoresis	NULL
on	NULL
a	NULL
5	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
7	NULL
M	NULL
urea	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
then	NULL
dried	NULL
under	NULL
vacuum	NULL
at	NULL
80	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
,	NULL
exposed	NULL
to	NULL
XAR-5	NULL
film	NULL
,	NULL
and	NULL
bands	NULL
corresponding	NULL
to	NULL
full-length	NULL
transcripts	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
densitometer	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

RESULTS	NULL
In	NULL
Vitro	NULL
Transcription	NULL
from	NULL
the	NULL
c-sis/PDGF-B	NULL
Promoter	NULL
Is	NULL
Enhanced	NULL
by	NULL
HTLV-1	NULL
Tax-The	NULL
effect	NULL
(	NULL
s	NULL
)	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
on	NULL
transcription	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
was	NULL
investigated	NULL
using	NULL
an	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
assay	NULL
supported	NULL
by	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
.	NULL

Transcription	NULL
from	NULL
the	NULL
template	NULL
DNA	NULL
fragment	NULL
,	NULL
containing	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
,	NULL
was	NULL
designed	NULL
to	NULL
generate	NULL
an	NULL
RNA	NULL
transcript	NULL
of	NULL
697	NULL
nucleotides	NULL
(	NULL
represented	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
lane	NULL
2	NULL
of	NULL
Fig	NULL
.	NULL

1B	NULL
demonstrate	NULL
that	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
is	NULL
efficiently	NULL
transcribed	NULL
using	NULL
stimulated	NULL
Jurkat	NULL
E6.1	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
assays	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
Tax	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
assays	NULL
resulted	NULL
in	NULL
an	NULL
11-fold	NULL
increase	NULL
in	NULL
transcription	NULL
above	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
compare	NULL
lane	NULL
3	NULL
versus	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
transactivation	NULL
activity	NULL
was	NULL
specific	NULL
to	NULL
Tax	NULL
,	NULL
a	NULL
control	NULL
extract	NULL
containing	NULL
no	NULL
Tax	NULL
protein	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
Zane	NULL
4	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
control	NULL
extract	NULL
did	NULL
not	NULL
result	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
transcrip-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27414	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
A	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
l—	NULL
e-sis/PDGF-B	NULL
Promoter	NULL
—*	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
sche-	NULL
+257	NULL
64	NULL
matic	NULL
representation	NULL
of	NULL
the	NULL
template	NULL
Neo	NULL
!	NULL

DNA	NULL
containing	NULL
the	NULL
c-sis/PDGF-B	NULL
pro	NULL
moter	NULL
used	NULL
in	NULL
the	NULL
in	NULL
vifro	NULL
transcription	NULL
B	NULL
reactions	NULL
.	NULL

Template	NULL
DNA	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

B	NULL
,	NULL
in	NULL
vitro	NULL
transcription	NULL
reactions	NULL
containing	NULL
nuclear	NULL
extract	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
(	NULL
lanes	NULL
1-12	NULL
)	NULL
,	NULL
and	NULL
template	NULL
DNA	NULL
(	NULL
500	NULL
ng	NULL
,	NULL
Stim	NULL
.	NULL

J.E6.1	NULL
NE	NULL
lanes	NULL
2-12	NULL
)	NULL
.	NULL

Lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
and	NULL
12	NULL
con-	NULL
Template	NULL
tain	NULL
8	NULL
pl	NULL
(	NULL
400	NULL
ng	NULL
)	NULL
of	NULL
purified	NULL
TaxH	NULL
,	NULL
.	NULL

Lane	NULL
4	NULL
contains	NULL
8	NULL
ul	NULL
of	NULL
control/mock	NULL
(	NULL
see	NULL
``	NULL
Ma-	NULL
Tax	NULL
Extract	NULL
terials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
TaxH	NULL
,	NULL
extract	NULL
.	NULL

Control	NULL
Extract	NULL
Lanes	NULL
5	NULL
and	NULL
6	NULL
contain	NULL
a-amanitin	NULL
(	NULL
5	NULL
pug/	NULL
p-amanitin	NULL
ml	NULL
)	NULL
.	NULL

Transcription	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
in	NULL
nucleotides	NULL
(	NULL
mf	NULL
)	NULL
.	NULL

Expected	NULL
transcript	NULL
size	NULL
of	NULL
697	NULL
nucleotides	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

B61	NULL
697	NULL
nt	NULL
738	NULL
ba	NULL
.	NULL

--	NULL
*	NULL
transcript	NULL
seis-492	NULL
369	NULL
tion	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
transcription	NULL
observed	NULL
in	NULL
our	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
assays	NULL
was	NULL
mediated	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
(	NULL
pol	NULL
II	NULL
)	NULL
,	NULL
the	NULL
pol	NULL
II	NULL
inhibitor	NULL
,	NULL
«	NULL
-amanitin	NULL
(	NULL
a	NULL
bicyclic	NULL
octapeptide	NULL
from	NULL
the	NULL
mushroom	NULL
Amanita	NULL
phalloides	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reactions	NULL
.	NULL

At	NULL
low	NULL
concentrations	NULL
,	NULL
a-amanitin	NULL
selectively	NULL
inhibits	NULL
pol	NULL
II-dependent	NULL
transcription	NULL
through	NULL
binding	NULL
to	NULL
the	NULL
largest	NULL
subunit	NULL
of	NULL
pol	NULL
II	NULL
and	NULL
blocking	NULL
transcription	NULL
elongation	NULL
(	NULL
46-49	NULL
)	NULL
.	NULL

Transcription	NULL
from	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
was	NULL
completely	NULL
abolished	NULL
upon	NULL
addition	NULL
of	NULL
«	NULL
-amanitin	NULL
to	NULL
5	NULL
ug/ml	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
transactivation	NULL
by	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
necessity	NULL
of	NULL
the	NULL
TRE	NULL
]	NULL
region	NULL
for	NULL
both	NULL
basal	NULL
transcription	NULL
and	NULL
transactivation	NULL
by	NULL
Tax	NULL
,	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
pRALuc	NULL
linker-insertion	NULL
mutants	NULL
-64/-55	NULL
,	NULL
-54/-45	NULL
,	NULL
and	NULL
-34/-25	NULL
as	NULL
tem-plates	NULL
.	NULL

Each	NULL
mutant	NULL
contains	NULL
a	NULL
10-bp	NULL
substitution	NULL
linker	NULL
sequence	NULL
at	NULL
the	NULL
designated	NULL
nucleotides	NULL
.	NULL

Mutants	NULL
-64/-55	NULL
and	NULL
-54/-45	NULL
disrupt	NULL
TRE1l	NULL
while	NULL
mutant	NULL
-34/-25	NULL
disrupts	NULL
the	NULL
TATA	NULL
box/initiator	NULL
region	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
transcription	NULL
from	NULL
the	NULL
mutant	NULL
templates	NULL
-64/-55	NULL
and	NULL
-54/-45	NULL
is	NULL
significantly	NULL
reduced	NULL
both	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
compare	NULL
lane	NULL
7	NULL
versus	NULL
lanes	NULL
1	NULL
and	NULL
8	NULL
,	NULL
and	NULL
lane	NULL
9	NULL
versus	NULL
lanes	NULL
1	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

When	NULL
the	NULL
TATA	NULL
box/initiator	NULL
region	NULL
is	NULL
disrupted	NULL
by	NULL
mutant	NULL
-34/-25	NULL
,	NULL
transcription	NULL
from	NULL
this	NULL
template	NULL
is	NULL
completely	NULL
abolished	NULL
in	NULL
both	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
Tax	NULL
's	NULL
ability	NULL
to	NULL
enhance	NULL
pol	NULL
II-dependent	NULL
transcription	NULL
from	NULL
the	NULL
c-sis/	NULL
PDGF-B	NULL
promoter	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
assay	NULL
along	NULL
with	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
the	NULL
TRE1	NULL
region	NULL
for	NULL
both	NULL
basal	NULL
transcription	NULL
and	NULL
Tax-mediated	NULL
transactivation	NULL
.	NULL

Site-directed	NULL
Mutagenesis	NULL
of	NULL
TRE1I-To	NULL
further	NULL
investigate	NULL
the	NULL
regulatory	NULL
region	NULL
contained	NULL
within	NULL
TRE1	NULL
,	NULL
a	NULL
series	NULL
of	NULL
c-sis/	NULL
PDGF-B	NULL
promoter	NULL
mutants	NULL
containing	NULL
high-resolution	NULL
mutations	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
within	NULL
TRE1	NULL
,	NULL
driving	NULL
expression	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
was	NULL
constructed	NULL
.	NULL

These	NULL
site-directed	NULL
TREL	NULL
TATA	NULL
I—	NULL
)	NULL
|_|	NULL
|_I	NULL
pRALue	NULL
Lue	NULL
l	NULL
Neol	NULL
-	NULL
EcoRI	NULL
|	NULL
[	NULL
oA	NULL
~	NULL
*	NULL
4	NULL
45	NULL
+84	NULL
+25	NULL
+74	NULL
+697	NULL
EcoRI	NULL
l	NULL
xP	NULL
x	NULL
>	NULL
x2	NULL
¢Q	NULL
a*	NULL
3*	NULL
Pua	NULL
«	NULL
5	NULL
¢Q	NULL
&	NULL
&	NULL
y	NULL
a	NULL
?	NULL

“	NULL
g	NULL
?	NULL

”	NULL
bﬁ	NULL
``	NULL
$	NULL
F	NULL
&	NULL
``	NULL
re	NULL
,	NULL
+o	NULL
4	NULL
oto	NULL
o	NULL
$	NULL
oto	NULL
o	NULL
$	NULL
+	NULL
4+	NULL
40+	NULL
4	NULL
+	NULL
#	NULL
-	NULL
+o	NULL
took	NULL
oto	NULL
o	NULL
$	NULL
4	NULL
+	NULL
+04	NULL
+o	NULL
o+	NULL
%	NULL
-o	NULL
-	NULL
pe-	NULL
-	NULL
e	NULL
-	NULL
$	NULL
-	NULL
$	NULL
o	NULL
#	NULL
m	NULL
ms	NULL
``	NULL
+	NULL
_-	NULL
P	NULL
m	NULL
w	NULL
P3	NULL
P	NULL
P	NULL
m	NULL
MW	NULL
1	NULL
2	NULL
3	NULL
4	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
t	NULL
1.25	NULL
£	NULL
<	NULL
G	NULL
g	NULL
0.75	NULL
ha	NULL
&	NULL
em	NULL
l	NULL
3	NULL
0.54	NULL
El	NULL
0	NULL
>	NULL
£	NULL
€	NULL
0.25-3	NULL
o-	NULL
o	NULL
t	NULL
Ix	NULL
&	NULL
r	NULL
co	NULL
co	NULL
ig	NULL
19	NULL
i9	NULL
5	NULL
a	NULL
Eo	NULL
f	NULL
fof	NULL
f	NULL
f	NULL
f	NULL
$	NULL
f	NULL
$	NULL
°	NULL
%	NULL
C	NULL
Mut	NULL
:	NULL
GAG	NULL
AA	NULL
CA	NULL
AA	NULL
CA	NULL
AG	NULL
AG	NULL
ATAGA	NULL
WT	NULL
:	NULL
ITCT	NULL
CC	NULL
Ac	NULL
CC	NULL
AIC	NULL
CT	NULL
CT	NULL
CGCACI	NULL
«	NULL
64/-55	NULL
-54/-45	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Relative	NULL
luciferase	NULL
activity	NULL
of	NULL
the	NULL
e-sis/PDGF-B	NULL
promoter	NULL
TRE	NULL
]	NULL
site-directed	NULL
mutants	NULL
.	NULL

Five	NULL
ug	NULL
of	NULL
each	NULL
reporter	NULL
construct	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat-Tax	NULL
cells	NULL
which	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
TPA	NULL
and	NULL
0.4	NULL
ug/ml	NULL
ionomycin	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subsequently	NULL
lysed	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

After	NULL
subtraction	NULL
of	NULL
background	NULL
activity	NULL
from	NULL
all	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
,	NULL
pRALuc	NULL
was	NULL
arbitrarily	NULL
given	NULL
a	NULL
value	NULL
of	NULL
1	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
transfections	NULL
were	NULL
adjusted	NULL
relative	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

The	NULL
individual	NULL
2-3	NULL
base	NULL
substitutions	NULL
(	NULL
YL1-YL-7	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
span	NULL
of	NULL
the	NULL
-64/-55	NULL
and	NULL
-54/-45	NULL
linker-scanning	NULL
substitution	NULL
mutants	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
1	NULL
S.D	NULL
.	NULL

calculated	NULL
from	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

mutants	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat-Tax	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
to	NULL
transiently	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
Egr-1	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
then	NULL
measured	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
mutants	NULL
YLO-YL3	NULL
each	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
A	NULL
Spl	NULL
DNA	NULL
ition	NULL
alter	NULL
Eg	NULL
]	NULL
DNA	NULL
ition	NULL
alter	NULL
Core	NULL
5	NULL
GCCCCACCCC	NULL
-	NULL
#	NULL
3-	NULL
-5	NULL
5'-	NULL
CNCCCNCNC	NULL
-	NULL
#	NULL
3	NULL
GNGGCNGNG	NULL
-5°	NULL
64	NULL
_	NULL
Bpl	NULL
Core	NULL
45	NULL
1	NULL
I	NULL
1	NULL
I	NULL
5-	NULL
TCTCCACCCACCTCTCGCAC	NULL
-3	NULL
3-	NULL
AGAGGTGGGTGGAGAGCGTG	NULL
-5	NULL
L______	NULL
#	NULL
I	NULL
Egr-1	NULL
Consensus	NULL
B	NULL
-	NULL
simitar	NULL
Regions	NULL
Found	NULL
in	NULL
the	NULL
&	NULL
IL-2	NULL
Promoters	NULL
:	NULL
64	NULL
Sp1	NULL
Core	NULL
45	NULL
I	NULL
POC	NULL
]	NULL
I	NULL
5'-	NULL
AACCAGCCCACCAGAGGAGG	NULL
-4	NULL
PTHrP	NULL
Promoter	NULL
:	NULL
3-	NULL
TTGGTCGGGTGGTCTCCTCC	NULL
-5	NULL
308	NULL
Sp1	NULL
Core	NULL
-280	NULL
I	NULL
I	NULL
1L-2	NULL
Promoter	NULL
:	NULL
5+	NULL
TGTATCCCCACCCCCTTAAAGAA	NULL
-9	NULL
3	NULL
ACATAGGGGTGGGGGAATTTCTT	NULL
.5	NULL
L_	NULL
22	NULL
Egr-1	NULL
Consensus	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

TRE1	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
contains	NULL
Spl	NULL
and	NULL
Egr-1	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequences	NULL
similar	NULL
to	NULL
those	NULL
found	NULL
in	NULL
the	NULL
Tax-responsive	NULL
promoters	NULL
of	NULL
the	NULL
PTHrP	NULL
and	NULL
IL-2	NULL
genes	NULL
.	NULL

A	NULL
,	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequences	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
Egr-1	NULL
.	NULL

The	NULL
``	NULL
CCACCC	NULL
``	NULL
motif	NULL
,	NULL
which	NULL
comprises	NULL
the	NULL
core	NULL
of	NULL
the	NULL
Sp1	NULL
DNA	NULL
recognition	NULL
sequence	NULL
,	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
CCACCC	NULL
core	NULL
motif	NULL
of	NULL
the	NULL
Spl	NULL
DNA	NULL
recognition	NULL
sequence	NULL
and	NULL
the	NULL
Eigr-1	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
contained	NULL
within	NULL
TRE	NULL
]	NULL
(	NULL
nucleo-tides	NULL
-64	NULL
to	NULL
-45	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
representation	NULL
of	NULL
the	NULL
Spl	NULL
CCACCC	NULL
core	NULL
motif	NULL
found	NULL
in	NULL
the	NULL
-64	NULL
to	NULL
-45	NULL
region	NULL
of	NULL
the	NULL
PTHrP	NULL
gene	NULL
promoter	NULL
,	NULL
and	NULL
,	NULL
the	NULL
Spl	NULL
CCACCC	NULL
core	NULL
motif	NULL
and	NULL
Eigr-1	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
found	NULL
in	NULL
the	NULL
-808	NULL
to	NULL
-280	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
.	NULL

@	NULL
indicates	NULL
a	NULL
nucleotide	NULL
which	NULL
does	NULL
not	NULL
conform	NULL
to	NULL
the	NULL
Eigr-1	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
.	NULL

resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
activity	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
either	NULL
of	NULL
the	NULL
two	NULL
10-bp	NULL
linker	NULL
insertion	NULL
mutants	NULL
,	NULL
-64/-55	NULL
and	NULL
-54/-45	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutants	NULL
YL4-YL7	NULL
were	NULL
each	NULL
significantly	NULL
lower	NULL
in	NULL
activity	NULL
than	NULL
the	NULL
wild-type	NULL
,	NULL
pRALuc	NULL
,	NULL
but	NULL
no	NULL
single	NULL
mutant	NULL
caused	NULL
a	NULL
reduction	NULL
equal	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
either	NULL
-64/-55	NULL
or	NULL
-54/-45	NULL
.	NULL

This	NULL
analysis	NULL
indicated	NULL
the	NULL
importance	NULL
of	NULL
a	NULL
CCACCC	NULL
motif	NULL
(	NULL
ablated	NULL
by	NULL
mutants	NULL
YL1-Y¥L3	NULL
)	NULL
,	NULL
along	NULL
with	NULL
the	NULL
importance	NULL
of	NULL
a	NULL
GNGNGGGNG	NULL
motif	NULL
(	NULL
ablated	NULL
by	NULL
mutants	NULL
YL1-YL5	NULL
)	NULL
,	NULL
for	NULL
Tax-responsiveness	NULL
.	NULL

The	NULL
CCACCC	NULL
motif	NULL
has	NULL
been	NULL
previously	NULL
identified	NULL
as	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
element	NULL
,	NULL
capable	NULL
of	NULL
binding	NULL
members	NULL
of	NULL
the	NULL
Sp	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
some	NULL
of	NULL
which	NULL
include	NULL
the	NULL
human	NULL
embryonic	NULL
eglobin	NULL
gene	NULL
(	NULL
50	NULL
)	NULL
,	NULL
the	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
(	NULL
PTHrP	NULL
)	NULL
gene	NULL
(	NULL
51	NULL
)	NULL
,	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
(	NULL
52	NULL
)	NULL
,	NULL
and	NULL
the	NULL
human	NULL
leukosia-lin	NULL
(	NULL
CD43	NULL
)	NULL
gene	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
GNGNGGGNG	NULL
motif	NULL
(	NULL
54	NULL
)	NULL
has	NULL
been	NULL
previously	NULL
identified	NULL
as	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
element	NULL
,	NULL
capable	NULL
of	NULL
binding	NULL
members	NULL
of	NULL
the	NULL
immediate-early	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
,	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
some	NULL
of	NULL
which	NULL
include	NULL
the	NULL
phenylethanolamine	NULL
N-methylItrans-ferase	NULL
gene	NULL
(	NULL
55	NULL
)	NULL
,	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
gene	NULL
(	NULL
56	NULL
)	NULL
,	NULL
and	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
are	NULL
the	NULL
consensus	NULL
DNA	NULL
binding	NULL
sequences	NULL
for	NULL
the	NULL
Sp	NULL
transcription	NULL
factor	NULL
family	NULL
member	NULL
,	NULL
Spl	NULL
(	NULL
57	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
CCACCC	NULL
motif	NULL
in	NULL
its	NULL
core	NULL
,	NULL
and	NULL
the	NULL
immediate-early	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
member	NULL
,	NULL
Egr-1	NULL
(	NULL
54	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
TRE1L	NULL
contains	NULL
both	NULL
the	NULL
Spl	NULL
core	NULL
recognition	NULL
sequence	NULL
and	NULL
the	NULL
Egr-1	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Initial	NULL
EMSA	NULL
analyses	NULL
of	NULL
T-cell	NULL
line	NULL
nuclear	NULL
proteins	NULL
that	NULL
bound	NULL
to	NULL
TRE1L	NULL
demonstrated	NULL
that	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
did	NULL
indeed	NULL
bind	NULL
to	NULL
TRE1	NULL
,	NULL
and	NULL
that	NULL
this	NULL
binding	NULL
was	NULL
essential	NULL
for	NULL
Tax	NULL
responsiveness	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Similar	NULL
regions	NULL
found	NULL
in	NULL
the	NULL
PTHrP	NULL
gene	NULL
promoter	NULL
and	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
,	NULL
two	NULL
genes	NULL
that	NULL
have	NULL
also	NULL
been	NULL
27415	NULL
demonstrated	NULL
to	NULL
be	NULL
transactivated	NULL
by	NULL
Tax	NULL
(	NULL
58	NULL
,	NULL
59	NULL
)	NULL
,	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

The	NULL
PTHrP	NULL
promoter	NULL
contains	NULL
the	NULL
core	NULL
of	NULL
the	NULL
Spl	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
(	NULL
the	NULL
CCACCC	NULL
motif	NULL
)	NULL
,	NULL
whereas	NULL
,	NULL
the	NULL
IL-2	NULL
promoter	NULL
contains	NULL
both	NULL
the	NULL
core	NULL
of	NULL
the	NULL
Spl	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
(	NULL
the	NULL
CCACCC	NULL
motif	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Egr-1	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequence	NULL
(	NULL
the	NULL
GNGNGGGNG	NULL
motif	NULL
)	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
Enhances	NULL
the	NULL
DNA	NULL
Binding	NULL
Activity	NULL
of	NULL
Sp1	NULL
and	NULL
Egr-1-With	NULL
the	NULL
knowledge	NULL
that	NULL
two	NULL
of	NULL
the	NULL
main	NULL
TRE1-binding	NULL
proteins	NULL
consisted	NULL
of	NULL
Spl	NULL
and	NULL
Egr-1	NULL
,	NULL
and	NULL
that	NULL
this	NULL
binding	NULL
was	NULL
essential	NULL
for	NULL
Tax	NULL
responsiveness	NULL
,	NULL
we	NULL
next	NULL
sought	NULL
to	NULL
investigate	NULL
whether	NULL
Tax	NULL
could	NULL
enhance	NULL
the	NULL
binding	NULL
of	NULL
either	NULL
Spl	NULL
or	NULL
Egr-1	NULL
,	NULL
or	NULL
both	NULL
,	NULL
to	NULL
TRE1	NULL
by	NULL
EMSA	NULL
analysis	NULL
.	NULL

A	NULL
previous	NULL
report	NULL
on	NULL
the	NULL
effects	NULL
of	NULL
Tax	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
demonstrated	NULL
that	NULL
Tax	NULL
enhanced	NULL
the	NULL
site-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
Spl	NULL
to	NULL
a	NULL
GC-rich	NULL
recognition	NULL
sequence	NULL
,	NULL
containing	NULL
a	NULL
CCACCC	NULL
motif	NULL
,	NULL
found	NULL
within	NULL
the	NULL
HTLV-1	NULL
promoter	NULL
(	NULL
13	NULL
)	NULL
.	NULL

This	NULL
Spl-binding	NULL
site	NULL
in	NULL
the	NULL
HTLV-1	NULL
promoter	NULL
is	NULL
located	NULL
in	NULL
a	NULL
region	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
Tax-responsive	NULL
in	NULL
vivo	NULL
(	NULL
60	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
Tax	NULL
dramatically	NULL
increased	NULL
the	NULL
amount	NULL
of	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
between	NULL
.	NULL

Spl	NULL
and	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TRE1l	NULL
site	NULL
(	NULL
compare	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
3	NULL
;	NULL
Spl	NULL
C1	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Tax	NULL
also	NULL
dramatically	NULL
increased	NULL
the	NULL
amount	NULL
of	NULL
protein-DNA	NULL
complex	NULL
formed	NULL
between	NULL
Egr-1	NULL
and	NULL
the	NULL
TREl	NULL
probe	NULL
(	NULL
compare	NULL
lane	NULL
6	NULL
versus	NULL
lane	NULL
7	NULL
;	NULL
Egr-1H	NULL
,	NULL
C1	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
TRE1	NULL
probe	NULL
since	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
TRE1	NULL
probe	NULL
competed	NULL
for	NULL
their	NULL
binding	NULL
(	NULL
ane	NULL
4	NULL
and	NULL
lane	NULL
8	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
Tax	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
of	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
also	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
additional	NULL
shifted	NULL
complex	NULL
(	NULL
Spl	NULL
C2	NULL
and	NULL
Egr-1H	NULL
,	NULL
C2	NULL
,	NULL
respectively	NULL
)	NULL
migrating	NULL
slower	NULL
than	NULL
either	NULL
Spl	NULL
C1	NULL
or	NULL
Egr-1H4	NULL
C1	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
CCACCC	NULL
and	NULL
GNGNGGGNG	NULL
motifs	NULL
,	NULL
contained	NULL
within	NULL
TRE1	NULL
,	NULL
for	NULL
Spl	NULL
and	NULL
Egr-1	NULL
binding	NULL
,	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Tax	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Tax	NULL
,	NULL
was	NULL
completely	NULL
abolished	NULL
when	NULL
a	NULL
probe	NULL
containing	NULL
both	NULL
a	NULL
mutated	NULL
CCACCC	NULL
motif	NULL
,	NULL
and	NULL
GNGNGGGNG	NULL
motif	NULL
,	NULL
was	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
analysis	NULL
(	NULL
lanes	NULL
9-13	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
Tax	NULL
's	NULL
ability	NULL
to	NULL
increase	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
,	NULL
Spl	NULL
and	NULL
Egr-1	NULL
,	NULL
to	NULL
TRE1	NULL
,	NULL
along	NULL
with	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
the	NULL
CCACCC	NULL
and	NULL
GNGNGGGNG	NULL
motifs	NULL
contained	NULL
within	NULL
Ternary	NULL
Complex	NULL
Formation	NULL
between	NULL
Either	NULL
Sp1	NULL
or	NULL
Egr-1	NULL
,	NULL
Tax	NULL
,	NULL
and	NULL
DNA-The	NULL
observation	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
Tax	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
additional	NULL
,	NULL
slower	NULL
migrating	NULL
,	NULL
shifted	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
Spl	NULL
C2	NULL
and	NULL
Egr-1H	NULL
,	NULL
,	NULL
C2	NULL
)	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
possibility	NULL
that	NULL
Tax	NULL
,	NULL
itself	NULL
,	NULL
was	NULL
stably	NULL
incorporated	NULL
into	NULL
the	NULL
complex	NULL
.	NULL

We	NULL
addressed	NULL
this	NULL
possibility	NULL
by	NULL
antibody	NULL
supershift	NULL
analysis	NULL
utilizing	NULL
the	NULL
TRE1	NULL
probe	NULL
mentioned	NULL
above	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
when	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
Tax	NULL
was	NULL
included	NULL
in	NULL
either	NULL
the	NULL
Spl	NULL
(	NULL
compare	NULL
lane	NULL
4	NULL
versus	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
Egr-1	NULL
(	NULL
compare	NULL
lane	NULL
7	NULL
versus	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
samples	NULL
containing	NULL
Tax	NULL
,	NULL
not	NULL
only	NULL
was	NULL
Tax-mediated	NULL
enhancement	NULL
of	NULL
binding	NULL
abolished	NULL
,	NULL
but	NULL
also	NULL
,	NULL
basal	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
Egr-1	NULL
was	NULL
completely	NULL
abolished	NULL
.	NULL

Sur-prisingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
anti-Tax	NULL
antibody	NULL
did	NULL
not	NULL
give	NULL
rise	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
antibody	NULL
supershifted	NULL
complexes	NULL
,	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
completely	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
all	NULL
shifted	NULL
complexes	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
antibody	NULL
directly	NULL
interfering	NULL
with	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
Spl	NULL
or	NULL
Egr-1	NULL
,	NULL
since	NULL
their	NULL
binding	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
the	NULL
antibody	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Zane	NULL
8	NULL
and	NULL
lane	NULL
9	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
effect	NULL
of	NULL
the	NULL
antibody	NULL
was	NULL
specific	NULL
for	NULL
Tax	NULL
,	NULL
since	NULL
preimmune	NULL
serum	NULL
did	NULL
not	NULL
affect	NULL
Tax-mediated	NULL
enhancement	NULL
of	NULL
either	NULL
Spl	NULL
or	NULL
Egr-1	NULL
binding	NULL
(	NULL
lane	NULL
10	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27416	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
8	NULL
``	NULL
qu	NULL
‘	NULL
so	NULL
“	NULL
24	NULL
&	NULL
®	NULL
f	NULL
ye	NULL
?	NULL

Qfxy	NULL
&	NULL
°	NULL
$	NULL
g	NULL
’	NULL
&	NULL
x	NULL
y	NULL
»	NULL
#	NULL
PSs	NULL
wsﬁyﬁ	NULL
“	NULL
ff	NULL
C	NULL
2	NULL
>	NULL
_	NULL
>	NULL
¥	NULL
®	NULL
a	NULL
&	NULL
¢	NULL
&	NULL
¢	NULL
&	NULL
#	NULL
&	NULL
o	NULL
of	NULL
1	NULL
8	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8s	NULL
g	NULL
10	NULL
11	NULL
12	NULL
13	NULL
Pt	NULL
*	NULL
Spl	NULL
C2	NULL
-	NULL
>	NULL
»	NULL
SiG	NULL
%	NULL
,	NULL
u	NULL
-e-Egr-1Hg	NULL
C2	NULL
’	NULL
.	NULL
'	NULL

-	NULL
«	NULL
-Egr-1Hg	NULL
C1	NULL
L	NULL
_L	NULL
]	NULL
TRE1	NULL
probe	NULL
TRE1-mSp1	NULL
probe	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Enhancement	NULL
of	NULL
Spl	NULL
and	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
Tax	NULL
.	NULL

DNA	NULL
binding	NULL
activities	NULL
of	NULL
Spl	NULL
and	NULL
Eigr-1	NULL
were	NULL
assayed	NULL
by	NULL
EMSA	NULL
analysis	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Tax	NULL
.	NULL

Purified	NULL
Spl	NULL
(	NULL
~1	NULL
ng	NULL
)	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
,	NULL
or	NULL
purified	NULL
Egr-1H	NULL
,	NULL
,	NULL
(	NULL
~1	NULL
ng	NULL
)	NULL
(	NULL
lanes	NULL
6-8	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TRE1	NULL
site	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
,	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
specificity	NULL
of	NULL
binding	NULL
,	NULL
Spl	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
and	NULL
Egr-1H	NULL
,	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
1000-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
TRE1	NULL
probe	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
TRE1	NULL
probe	NULL
was	NULL
incubated	NULL
by	NULL
itself	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
TaxH	NULL
,	NULL
,	NULL
only	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
TRE1	NULL
for	NULL
Spl	NULL
and	NULL
Egr-1H	NULL
,	NULL
,	NULL
binding	NULL
,	NULL
Sp1	NULL
and	NULL
Egr-1H	NULL
,	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
mutated	NULL
TRE1	NULL
site	NULL
,	NULL
TRE1-mSpl	NULL
(	NULL
see	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
anes	NULL
10	NULL
and	NULL
12	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
(	NULL
Zanes	NULL
11	NULL
and	NULL
13	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
using	NULL
dilutions	NULL
of	NULL
TaxH	NULL
,	NULL
,	NULL
down	NULL
to	NULL
25	NULL
ng	NULL
.	NULL

Spl	NULL
shifted	NULL
complexes	NULL
,	NULL
Spl	NULL
C1	NULL
and	NULL
Spl	NULL
C2	NULL
,	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
side	NULL
of	NULL
the	NULL
gel	NULL
by	NULL
arrows	NULL
.	NULL

Egr-1H	NULL
,	NULL
shifted	NULL
complexes	NULL
,	NULL
Egr-1H	NULL
,	NULL
C1	NULL
and	NULL
Egr-1H	NULL
,	NULL
,	NULL
C2	NULL
,	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
gel	NULL
by	NULL
arrows	NULL
.	NULL

Lanes	NULL
containing	NULL
TRE1	NULL
probe	NULL
,	NULL
or	NULL
the	NULL
mutated	NULL
TRE1	NULL
probe	NULL
,	NULL
TRE1-mSp1l	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

Q	NULL
‘	NULL
eva	NULL
£15913	NULL
,	NULL
“	NULL
23	NULL
,	NULL
&	NULL
°§	NULL
.	NULL

$	NULL
0	NULL
&	NULL
j®¢	NULL
;	NULL
y°	NULL
490	NULL
N	NULL
I	NULL
hs	NULL
©	NULL
y	NULL
*	NULL
a	NULL
COR	NULL
F	NULL
&	NULL
$	NULL
8	NULL
&	NULL
&	NULL
€	NULL
&	NULL
&	NULL
3	NULL
10	NULL
2	NULL
%	NULL
8	NULL
4	NULL
50	NULL
60	NULL
70	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
1	NULL
6	NULL
A	NULL
Sp1	NULL
C2	NULL
-	NULL
>	NULL
»	NULL
-	NULL
<	NULL
-*nsp	NULL
Spl	NULL
C1	NULL
-	NULL
>	NULL
»	NULL
(	NULL
a	NULL
-e-Egr-1Hg	NULL
C2	NULL
u	NULL
“	NULL
Fd	NULL
-e-Egr-1Hg	NULL
C1	NULL
TREL1	NULL
probe	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Inhibition	NULL
of	NULL
Tax-mediated	NULL
enhancement	NULL
of	NULL
Spl	NULL
and	NULL
Egr-1	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
Tax-specific	NULL
antisera	NULL
.	NULL

Spl	NULL
and	NULL
Egr-l	NULL
Tax-mediated	NULL
supershift	NULL
complex	NULL
formation	NULL
was	NULL
assayed	NULL
by	NULL
EMSA	NULL
analysis	NULL
using	NULL
Tax-specific	NULL
antisera	NULL
.	NULL

Purified	NULL
Spl	NULL
(	NULL
~1	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TRE1	NULL
site	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
either	NULL
alone	NULL
(	NULL
ane	NULL
2	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
and	NULL
2	NULL
pul	NULL
of	NULL
Tax-antisera	NULL
(	NULL
@	NULL
TaxC	NULL
Ab	NULL
)	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

Purified	NULL
Egr-1H	NULL
,	NULL
(	NULL
~1	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TRE1	NULL
site	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
alone	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
,	NULL
(	NULL
Fane	NULL
6	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
and	NULL
2	NULL
ul	NULL
of	NULL
aTaxC	NULL
Ab	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
eTaxC	NULL
Ab	NULL
did	NULL
not	NULL
effect	NULL
Spl	NULL
or	NULL
Egr-1H	NULL
,	NULL
,	NULL
binding	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TaxH	NULL
,	NULL
,	NULL
both	NULL
Sp1	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
and	NULL
Egr-1H	NULL
,	NULL
,	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
aTaxC	NULL
Ab	NULL
alone	NULL
.	NULL

Specificity	NULL
of	NULL
eTaxC	NULL
Ab	NULL
is	NULL
demonstrated	NULL
by	NULL
incubation	NULL
of	NULL
either	NULL
Spl	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
or	NULL
Egr-1H	NULL
,	NULL
(	NULL
Zane	NULL
11	NULL
)	NULL
,	NULL
with	NULL
preimmune	NULL
sera	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TaxH	NULL
,	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
TRE1L	NULL
probe	NULL
was	NULL
incubated	NULL
by	NULL
itself	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
with	NULL
«	NULL
TaxC	NULL
Ab	NULL
only	NULL
(	NULL
Zane	NULL
12	NULL
)	NULL
,	NULL
or	NULL
with	NULL
preimmune	NULL
sera	NULL
only	NULL
(	NULL
lane	NULL
13	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Sp1	NULL
shifted	NULL
complexes	NULL
,	NULL
Spl	NULL
C1	NULL
and	NULL
Spl	NULL
C2	NULL
,	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
side	NULL
of	NULL
the	NULL
gel	NULL
by	NULL
arrows	NULL
.	NULL

Egr-1H	NULL
,	NULL
,	NULL
shifted	NULL
complexes	NULL
,	NULL
Egr-1H	NULL
,	NULL
,	NULL
C1	NULL
and	NULL
Egr-1H	NULL
,	NULL
C2	NULL
,	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
side	NULL
of	NULL
the	NULL
gel	NULL
by	NULL
arrows	NULL
.	NULL

*nsp	NULL
indicates	NULL
a	NULL
nonspecific	NULL
shifted	NULL
complex	NULL
.	NULL

and	NULL
lane	NULL
11	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
support	NULL
the	NULL
possibility	NULL
that	NULL
Tax	NULL
is	NULL
incorporated	NULL
into	NULL
the	NULL
shifted	NULL
complexes	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
ternary	NULL
complexes	NULL
,	NULL
possibly	NULL
through	NULL
protein-protein	NULL
contacts	NULL
with	NULL
Spl	NULL
and	NULL
Eigr-1	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
Physically	NULL
Interacts	NULL
with	NULL
Both	NULL
Sp1	NULL
and	NULL
Egr-1-To	NULL
investigate	NULL
the	NULL
potential	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
either	NULL
Spl	NULL
or	NULL
Egr-1	NULL
,	NULL
in	NULL
vitro	NULL
co-immunoprecipitation	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
purified	NULL
proteins	NULL
.	NULL

Samples	NULL
containing	NULL
either	NULL
Sp1	NULL
,	NULL
plus	NULL
and	NULL
minus	NULL
TaxH	NULL
,	NULL
,	NULL
or	NULL
Egr-1H,4	NULL
,	NULL
plus	NULL
and	NULL
minus	NULL
TaxH	NULL
,	NULL
were	NULL
incubated	NULL
in	NULL
Superdex	NULL
buffer	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
«	NULL
-Tax	NULL
monoclonal	NULL
antibodies	NULL
and	NULL
the	NULL
immune	NULL
com	NULL
plexes	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
for	NULL
co-immunoprecipitation	NULL
reactions	NULL
involving	NULL
Spl	NULL
,	NULL
a	NULL
band	NULL
of	NULL
approximately	NULL
95	NULL
kDa	NULL
(	NULL
corresponding	NULL
to	NULL
Spl	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
for	NULL
co-immunoprecipitation	NULL
reactions	NULL
involving	NULL
Egr-1H4	NULL
,	NULL
a	NULL
band	NULL
of	NULL
approximately	NULL
85	NULL
kDa	NULL
(	NULL
corresponding	NULL
to	NULL
Egr-1H	NULL
,	NULL
,	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
TaxH	NULL
,	NULL
were	NULL
immunoprecipitated	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
A	NULL
$	NULL
*	NULL
S	NULL
$	NULL
so	NULL
$	NULL
8	NULL
8	NULL
o®	NULL
4T	NULL
}	NULL
x	NULL
x	NULL
$	NULL
3	NULL
(	NULL
3	NULL
CP	NULL
F	NULL
Fo	NULL
8	NULL
«	NULL
5	NULL
kDa	NULL
af	NULL
``	NULL
ef	NULL
a¥	NULL
«	NULL
¥	NULL
®	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
137	NULL
--	NULL
--	NULL
Spl	NULL
79	NULL
--	NULL
IP	NULL
c-Tax	NULL
WB	NULL
o-Spl	NULL
B	NULL
$	NULL
®	NULL
B	NULL
&	NULL
as	NULL
&	NULL
,	NULL
C	NULL
.	NULL

#	NULL
«	NULL
$	NULL
``	NULL
6	NULL
o	NULL
``	NULL
$	NULL
its	NULL
-	NULL
$	NULL
P	NULL
&	NULL
&	NULL
$	NULL
&	NULL
s	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
137	NULL
-e-	NULL
Egr-1Hg	NULL
T9	NULL
--	NULL
-6	NULL
--	NULL
Heavy	NULL
Chain	NULL
o-Tax	NULL
WB	NULL
.	NULL

:	NULL
-	NULL
o-Egr-l	NULL
C	NULL
$	NULL
°	NULL
¥	NULL
s	NULL
$	NULL
@	NULL
«	NULL
#	NULL
&	NULL
&	NULL
o	NULL
``	NULL
”	NULL
032	NULL
xQ	NULL
’	NULL
x	NULL
6:00	NULL
*	NULL
fa	NULL
$	NULL
*	NULL
3	NULL
’	NULL
6	NULL
woo	NULL
é	NULL
”	NULL
<	NULL
®	NULL
2	NULL
<	NULL
kDa	NULL
€	NULL
hs	NULL
5	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
42.3	NULL
--	NULL
Cap	NULL
cp	NULL
ep	NULL
--	NULL
TaxHg	NULL
31.6	NULL
IP	NULL
.	NULL

:	NULL
o-Tax	NULL
WB	NULL
.	NULL

:	NULL
o-Tax	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Co-immunoprecipitation	NULL
of	NULL
purified	NULL
Spl	NULL
and	NULL
Egr-1	NULL
with	NULL
purified	NULL
Tax	NULL
.	NULL

Either	NULL
~200	NULL
ng	NULL
of	NULL
purified	NULL
Spl	NULL
and	NULL
~400	NULL
ng	NULL
of	NULL
purified	NULL
TaxH	NULL
,	NULL
or	NULL
~200	NULL
ng	NULL
of	NULL
purified	NULL
Egr-1H	NULL
,	NULL
,	NULL
and	NULL
~400	NULL
ng	NULL
of	NULL
purified	NULL
TaxH	NULL
,	NULL
were	NULL
preincubated	NULL
in	NULL
1	NULL
X	NULL
Superdex	NULL
buffer	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
co-immunoprecipitation	NULL
(	NULL
Co-IP	NULL
)	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

A	NULL
,	NULL
immunoblot	NULL
against	NULL
Spl	NULL
demonstrating	NULL
co-immunoprecipitation	NULL
(	NULL
Co-IP	NULL
)	NULL
with	NULL
TaxH	NULL
,	NULL
using	NULL
aTax	NULL
mAbs	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
Spl	NULL
band	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

B	NULL
,	NULL
immunoblot	NULL
against	NULL
Egr-1H	NULL
,	NULL
,	NULL
demonstrating	NULL
co-immunoprecipitation	NULL
with	NULL
TaxH	NULL
,	NULL
,	NULL
using	NULL
aTax	NULL
mAbs	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

A	NULL
mouse	NULL
secondary	NULL
antibody	NULL
,	NULL
recognizing	NULL
the	NULL
heavy	NULL
chain	NULL
component	NULL
of	NULL
the	NULL
«	NULL
Tax	NULL
mAbs	NULL
,	NULL
was	NULL
included	NULL
in	NULL
the	NULL
co-immunoprecipitation	NULL
reaction	NULL
to	NULL
demonstrate	NULL
equivalent	NULL
amounts	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
sample	NULL
(	NULL
Fanes	NULL
1-6	NULL
)	NULL
.	NULL

*	NULL
indicates	NULL
a	NULL
nonspecific	NULL
band	NULL
.	NULL

The	NULL
Egr-1H	NULL
,	NULL
,	NULL
heavy	NULL
chain	NULL
,	NULL
and	NULL
*	NULL
nonspecific	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

C	NULL
,	NULL
immunoblot	NULL
against	NULL
TaxH	NULL
,	NULL
demonstrating	NULL
equivalent	NULL
amounts	NULL
of	NULL
TaxH	NULL
,	NULL
protein	NULL
in	NULL
each	NULL
co-immunoprecipitation	NULL
reaction	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
TaxH	NULL
,	NULL
bands	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
gel	NULL
by	NULL
arrows	NULL
.	NULL

Negative	NULL
controls	NULL
are	NULL
included	NULL
in	NULL
Zanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
in	NULL
each	NULL
panel	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
(	NULL
kDa	NULL
)	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

WB	NULL
,	NULL
Western	NULL
blot	NULL
.	NULL

each	NULL
sample	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
the	NULL
relevance	NULL
of	NULL
these	NULL
interactions	NULL
,	NULL
co-immunoprecipitation	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
whole	NULL
cell	NULL
extracts	NULL
prepared	NULL
from	NULL
the	NULL
HTLV-1	NULL
infected	NULL
T-cell	NULL
line	NULL
,	NULL
MT2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
for	NULL
co-immunoprecipitation	NULL
reactions	NULL
involving	NULL
Spl	NULL
,	NULL
a	NULL
band	NULL
of	NULL
approximately	NULL
95	NULL
kDa	NULL
(	NULL
corresponding	NULL
to	NULL
Spl	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a-Tax	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
«	NULL
-Tax	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
band	NULL
also	NULL
comigrated	NULL
with	NULL
the	NULL
bands	NULL
detected	NULL
in	NULL
the	NULL
positive	NULL
control	NULL
samples	NULL
27417	NULL
A	NULL
MT2	NULL
WCE	NULL
(	NULL
+	NULL
)	NULL
«	NULL
Tax	NULL
mAbs	NULL
+	NULL
_	NULL
_	NULL
se	NULL
me	NULL
MT2	NULL
WCE	NULL
(	NULL
-	NULL
)	NULL
«	NULL
Tax	NULL
mAbs	NULL
|	NULL
-	NULL
+	NULL
-	NULL
-	NULL
TaxHg	NULL
-	NULL
-	NULL
%	NULL
a	NULL
we	NULL
J.E6.1	NULL
N.E	NULL
.	NULL

Stim	NULL
.	NULL

=	NULL
-	NULL
-	NULL
0	NULL
-	NULL
0	NULL
#	NULL
$	NULL
Sp1	NULL
=	NULL
>	NULL
<	NULL
-	NULL
o-	NULL
o=	NULL
#	NULL
kDa	NULL
10	NULL
2	NULL
8	NULL
4	NULL
5	NULL
137	NULL
70	NULL
-_	NULL
<	NULL
-	NULL
Spl	NULL
WB	NULL
:	NULL
aSp1l	NULL
42.3	NULL
--	NULL
31.6	NULL
137	NULL
TQ	NULL
sam	NULL
WB	NULL
:	NULL
oTaxC	NULL
42.3	NULL
-	NULL
|	NULL
«	NULL
am	NULL
»	NULL
same	NULL
31.6	NULL
<	NULL
-	NULL
Tax	NULL
IP	NULL
:	NULL
cTax	NULL
mAbs	NULL
B	NULL
MT2	NULL
WCE	NULL
(	NULL
+	NULL
)	NULL
cTax	NULL
mAbs	NULL
MT2	NULL
WCE	NULL
(	NULL
-	NULL
)	NULL
cTax	NULL
mAbs	NULL
-	NULL
+	NULL
=~	NULL
TaxHg	NULL
-	NULL
=-	NULL
+	NULL
=	NULL
J.E6.1	NULL
N.E	NULL
.	NULL

Stim	NULL
.	NULL

-	NULL
-	NULL
-	NULL
+	NULL
kDa	NULL
1	NULL
2	NULL
3	NULL
4	NULL
137	NULL
-	NULL
<	NULL
-	NULL
Egr-1	NULL
42.3	NULL
31.6	NULL
137	NULL
T9	NULL
-=	NULL
123	NULL
-|	NULL
-	NULL
em	NULL
can	NULL
31.6	NULL
<	NULL
-	NULL
Tax	NULL
IP	NULL
:	NULL
cTax	NULL
mAbs	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Co-immunoprecipitation	NULL
of	NULL
Spl	NULL
and	NULL
Egr-1	NULL
with	NULL
Tax	NULL
from	NULL
HTLV-1	NULL
infected	NULL
T-cells	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
100	NULL
x	NULL
10°	NULL
MT2	NULL
cells	NULL
and	NULL
co-immunoprecipitation	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

A	NULL
,	NULL
immunoblots	NULL
against	NULL
Spl	NULL
and	NULL
Tax	NULL
demonstrating	NULL
co-immunoprecipitation	NULL
(	NULL
Co-IP	NULL
)	NULL
of	NULL
Spl	NULL
with	NULL
Tax	NULL
using	NULL
«	NULL
Tax	NULL
mAbs	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
Spl	NULL
and	NULL
Tax	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
each	NULL
gel	NULL
.	NULL

B	NULL
,	NULL
immunoblots	NULL
against	NULL
Egr-1	NULL
and	NULL
Tax	NULL
demonstrating	NULL
Co-IP	NULL
of	NULL
Egr-1	NULL
with	NULL
Tax	NULL
using	NULL
oTax	NULL
mAbs	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
Egr-1	NULL
and	NULL
Tax	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
each	NULL
gel	NULL
.	NULL

Negative	NULL
controls	NULL
are	NULL
included	NULL
in	NULL
lane	NULL
2	NULL
of	NULL
each	NULL
immunoblot	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Positive	NULL
controls	NULL
for	NULL
Spl	NULL
are	NULL
included	NULL
in	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
in	NULL
the	NULL
Spl	NULL
Western	NULL
blot	NULL
(	NULL
WB	NULL
)	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

Positive	NULL
controls	NULL
for	NULL
Egr-1	NULL
are	NULL
included	NULL
in	NULL
lane	NULL
4	NULL
in	NULL
the	NULL
Egr-1	NULL
WB	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

Positive	NULL
controls	NULL
for	NULL
Tax	NULL
are	NULL
included	NULL
in	NULL
lane	NULL
3	NULL
in	NULL
the	NULL
Tax	NULL
Western	NULL
blot	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B.	NULL
Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indi-	NULL
cated	NULL
in	NULL
kilodaltons	NULL
(	NULL
kDa	NULL
)	NULL
to	NULL
the	NULL
eft	NULL
of	NULL
each	NULL
individual	NULL
Western	NULL
blot	NULL
.	NULL

using	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
mitogen-stimulated	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
and	NULL
purified	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
for	NULL
co-immunoprecipitation	NULL
reactions	NULL
involving	NULL
Egr-1	NULL
,	NULL
a	NULL
band	NULL
of	NULL
approximately	NULL
85	NULL
kDa	NULL
(	NULL
corresponding	NULL
to	NULL
Egr-1	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
«	NULL
-Tax	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
«	NULL
e-Tax	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
band	NULL
also	NULL
comigrated	NULL
with	NULL
the	NULL
band	NULL
detected	NULL
in	NULL
the	NULL
positive	NULL
control	NULL
sample	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27418	NULL
16	NULL
14	NULL
4	NULL
12	NULL
10	NULL
4	NULL
8	NULL
~	NULL
6	NULL
Fold	NULL
Induction	NULL
&	NULL
s	NULL
gr	NULL
$	NULL
&	NULL
&	NULL
``	NULL
xéy	NULL
8	NULL
-	NULL
,	NULL
J	NULL
/	NULL
#	NULL
¢	NULL
&	NULL
00x	NULL
x	NULL
00x	NULL
O	NULL
‘	NULL
Ix	NULL
ap	NULL
CV	NULL
&	NULL
¢	NULL
¢	NULL
g	NULL
Constructs	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Transactivation	NULL
ability	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
mutants	NULL
on	NULL
the	NULL
e-sis	NULL
[	NULL
PDGF-B	NULL
promoter	NULL
in	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
.	NULL

One	NULL
ug	NULL
of	NULL
the	NULL
pRALuc	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
either	NULL
alone	NULL
or	NULL
cotransfected	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
wild-type	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
IEX	NULL
,	NULL
or	NULL
the	NULL
Tax	NULL
mutant	NULL
expression	NULL
plasmids	NULL
IEXS10A	NULL
,	NULL
IEXC29S	NULL
,	NULL
IEXH4S3Q	NULL
,	NULL
IEXS258A	NULL
,	NULL
and	NULL
IEXL820G	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
10	NULL
ng/ml	NULL
TPA	NULL
and	NULL
0.4	NULL
pg/ml	NULL
ionomycin	NULL
and	NULL
subsequently	NULL
lysed	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

After	NULL
subtraction	NULL
of	NULL
background	NULL
activity	NULL
from	NULL
all	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
,	NULL
pRALuc	NULL
was	NULL
arbitrarily	NULL
designated	NULL
as	NULL
1	NULL
X	NULL
fold	NULL
induction	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
transfections	NULL
were	NULL
adjusted	NULL
relative	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

Krror	NULL
bars	NULL
represent	NULL
1	NULL
S.D	NULL
.	NULL

calculated	NULL
from	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

using	NULL
nuclear	NULL
extract	NULL
prepared	NULL
from	NULL
mitogen-stimulated	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
Tax	NULL
physically	NULL
interacts	NULL
with	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
,	NULL
through	NULL
protein-protein	NULL
contacts	NULL
.	NULL

Ability	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
Mutants	NULL
to	NULL
Transactivate	NULL
the	NULL
c-sis/	NULL
PDGF-B	NULL
Promoter-To	NULL
examine	NULL
the	NULL
transactivation	NULL
activities	NULL
of	NULL
Tax	NULL
mutants	NULL
on	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
,	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
pRALuc	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
either	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
the	NULL
wild-type	NULL
or	NULL
mutant	NULL
Tax	NULL
expression	NULL
plasmids	NULL
,	NULL
IEX	NULL
,	NULL
IEXS10A	NULL
,	NULL
IEXC29S5	NULL
,	NULL
IEXH43Q	NULL
,	NULL
IEXS258A	NULL
,	NULL
and	NULL
IEXL8320G	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
to	NULL
transiently	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
Egr-1	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
then	NULL
measured	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
wild-type	NULL
Tax	NULL
,	NULL
IEX	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
greater	NULL
than	NULL
14-fold	NULL
induction	NULL
of	NULL
the	NULL
e-sis/PDGF-B	NULL
promoter	NULL
and	NULL
Tax	NULL
mutants	NULL
IEXS10A	NULL
,	NULL
IEXH43Q	NULL
,	NULL
and	NULL
IEXS258A	NULL
all	NULL
resulted	NULL
in	NULL
a	NULL
4-fold	NULL
or	NULL
greater	NULL
induction	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Tax	NULL
mutants	NULL
IEXC298	NULL
(	NULL
<	NULL
2-fold	NULL
)	NULL
and	NULL
IEXL320G	NULL
(	NULL
2-fold	NULL
)	NULL
were	NULL
significantly	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

Analysis	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
Mutants	NULL
IEXC29S	NULL
and	NULL
IEXL320G	NULL
to	NULL
Interact	NULL
with	NULL
Egr-1-With	NULL
the	NULL
knowledge	NULL
that	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
mutants	NULL
IEXC29S	NULL
and	NULL
IEXL820G	NULL
were	NULL
unable	NULL
to	NULL
significantly	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
this	NULL
might	NULL
be	NULL
a	NULL
result	NULL
of	NULL
their	NULL
inability	NULL
to	NULL
interact	NULL
with	NULL
Egr-1	NULL
.	NULL

The	NULL
idea	NULL
of	NULL
focusing	NULL
on	NULL
the	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
Egr-1	NULL
,	NULL
and	NULL
not	NULL
Tax	NULL
and	NULL
Sp1	NULL
,	NULL
is	NULL
based	NULL
on	NULL
the	NULL
observations	NULL
that	NULL
Spl	NULL
and	NULL
Egr-1-binding	NULL
sites	NULL
in	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
overlap	NULL
and	NULL
Spl	NULL
is	NULL
displaced	NULL
by	NULL
increasing	NULL
amounts	NULL
of	NULL
Egr-1	NULL
that	NULL
arise	NULL
upon	NULL
stimulation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
Tax-Egr-1	NULL
interactions	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
co-immunoprecipitation	NULL
reactions	NULL
in	NULL
which	NULL
the	NULL
wild-type	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
IEX	NULL
,	NULL
or	NULL
the	NULL
Tax	NULL
mutant	NULL
expression	NULL
plasmids	NULL
,	NULL
IEXC295	NULL
and	NULL
IEXL320G	NULL
,	NULL
were	NULL
transiently	NULL
cotransfected	NULL
into	NULL
COS-7	NULL
cells	NULL
along	NULL
with	NULL
the	NULL
Egr-1	NULL
expression	NULL
plasmid	NULL
,	NULL
pJDM948	NULL
,	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
«	NULL
e-Tax	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
a	NULL
band	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
137	NULL
-=	NULL
70	NULL
)	NULL
=a	NULL
i=	NULL
tt	NULL
#	NULL
#	NULL
|	NULL
<	NULL
-	NULL
Egr-l	NULL
WB	NULL
:	NULL
cEgr-1	NULL
42.3	NULL
===	NULL
31.6	NULL
--	NULL
=	NULL
79	NULL
«	NULL
==	NULL
WB	NULL
:	NULL
cTaxC	NULL
im	NULL
as	NULL
a	NULL
wa	NULL
as	NULL
wt	NULL
<	NULL
-	NULL
Tax	NULL
42.3	NULL
===	NULL
31.6	NULL
IP	NULL
:	NULL
cTax	NULL
mAbs	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Co-immunoprecipitation	NULL
analysis	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
mutants	NULL
and	NULL
Egr-1	NULL
.	NULL

Five	NULL
ug	NULL
of	NULL
the	NULL
wild-type	NULL
Tax	NULL
expression	NULL
plasmid	NULL
,	NULL
IEX	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
or	NULL
the	NULL
Tax	NULL
mutant	NULL
expression	NULL
plasmids	NULL
IEXC298S	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
IEXL320G	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
,	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
COS-7	NULL
cells	NULL
either	NULL
alone	NULL
or	NULL
cotransfected	NULL
with	NULL
the	NULL
Egr-1	NULL
expression	NULL
plasmid	NULL
,	NULL
pJDM948	NULL
(	NULL
lanes	NULL
5-7	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
co-immunoprecipitation	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Five	NULL
ug	NULL
of	NULL
pJDM948	NULL
was	NULL
also	NULL
transfected	NULL
alone	NULL
into	NULL
COS-7	NULL
cells	NULL
as	NULL
a	NULL
control	NULL
for	NULL
Egr-1	NULL
expression	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

For	NULL
the	NULL
Egr-1	NULL
alone	NULL
sample	NULL
,	NULL
a	NULL
whole	NULL
cell	NULL
extract	NULL
was	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
an	NULL
ethanol/dry	NULL
ice	NULL
bath	NULL
and	NULL
37	NULL
°C	NULL
water	NULL
bath	NULL
.	NULL

Western	NULL
blots	NULL
(	NULL
WB	NULL
)	NULL
for	NULL
Egr-1	NULL
and	NULL
Tax	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
Zeft	NULL
of	NULL
each	NULL
blot	NULL
.	NULL

The	NULL
Egr-1	NULL
and	NULL
Tax	NULL
bands	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
each	NULL
gel	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
(	NULL
kDa	NULL
)	NULL
to	NULL
the	NULL
left	NULL
of	NULL
each	NULL
individual	NULL
Western	NULL
blot	NULL
.	NULL

of	NULL
approximately	NULL
85	NULL
kDa	NULL
,	NULL
corresponding	NULL
to	NULL
Egr-1	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
containing	NULL
wild-type	NULL
Tax	NULL
,	NULL
IEX	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
interestingly	NULL
,	NULL
also	NULL
in	NULL
the	NULL
sample	NULL
containing	NULL
the	NULL
Tax	NULL
mutant	NULL
IEXL320G	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

This	NULL
band	NULL
also	NULL
comigrated	NULL
with	NULL
the	NULL
band	NULL
detected	NULL
in	NULL
the	NULL
positive	NULL
control	NULL
sample	NULL
using	NULL
a	NULL
whole	NULL
cell	NULL
extract	NULL
prepared	NULL
from	NULL
COS-7	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Eigr-1	NULL
expression	NULL
plasmid	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
this	NULL
same	NULL
band	NULL
,	NULL
corresponding	NULL
to	NULL
Egr-1	NULL
,	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
sample	NULL
containing	NULL
the	NULL
Tax	NULL
mutant	NULL
IEXC29S5	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
protein-protein	NULL
interactions	NULL
between	NULL
Tax	NULL
and	NULL
Egr-1	NULL
are	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
to	NULL
support	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
mechanism	NULL
of	NULL
HTLV-1	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
and	NULL
site-directed	NULL
mutation	NULL
analysis	NULL
,	NULL
along	NULL
with	NULL
EMSA	NULL
and	NULL
co-immunoprecipitation	NULL
analysis	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
analysis	NULL
that	NULL
addition	NULL
of	NULL
Tax	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
led	NULL
to	NULL
an	NULL
11-fold	NULL
increase	NULL
in	NULL
RNA	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
compare	NULL
lane	NULL
3	NULL
versus	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
that	NULL
Tax-mediated	NULL
in	NULL
vitro	NULL
transcription	NULL
from	NULL
the	NULL
HTLV-1	NULL
promoter	NULL
is	NULL
resistant	NULL
to	NULL
low	NULL
levels	NULL
of	NULL
e-amanitin	NULL
(	NULL
at	NULL
low	NULL
concentrations	NULL
,	NULL
a	NULL
«	NULL
-amanitin	NULL
selectively	NULL
inhibits	NULL
RNA	NULL
pol	NULL
II	NULL
)	NULL
in	NULL
reactions	NULL
containing	NULL
either	NULL
HeLa	NULL
or	NULL
CEM	NULL
T-cell	NULL
extract	NULL
.	NULL

This	NULL
is	NULL
surprising	NULL
in	NULL
light	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
HTLV-1	NULL
promoter	NULL
contains	NULL
all	NULL
of	NULL
the	NULL
structural	NULL
features	NULL
of	NULL
a	NULL
typical	NULL
RNA	NULL
pol	NULL
II	NULL
transcription	NULL
tem-plate	NULL
:	NULL
a	NULL
TATA	NULL
box	NULL
~30	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
pol	NULL
II	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
long	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
RNA	NULL
is	NULL
synthesized	NULL
from	NULL
the	NULL
integrated	NULL
HTLV-1	NULL
proviral	NULL
DNA	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
vitro	NULL
transcription	NULL
experiments	NULL
,	NULL
supported	NULL
by	NULL
either	NULL
Hela	NULL
or	NULL
CEM	NULL
T-cell	NULL
extracts	NULL
,	NULL
showed	NULL
that	NULL
the	NULL
HTLV-1	NULL
promoter	NULL
contains	NULL
overlapping	NULL
transcription	NULL
units	NULL
which	NULL
utilize	NULL
the	NULL
same	NULL
transcription	NULL
initiation	NULL
site	NULL
as	NULL
that	NULL
of	NULL
pol	NULL
II-dependent	NULL
transcription	NULL
.	NULL

Fur	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
thermore	NULL
,	NULL
neutralization	NULL
and	NULL
depletion	NULL
experiments	NULL
with	NULL
pol	NULL
II	NULL
antibodies	NULL
strongly	NULL
suggested	NULL
that	NULL
classical	NULL
pol	NULL
II	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
HTLV-1	NULL
overlapping	NULL
transcription	NULL
unit	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
e-sis/PDGF-B	NULL
promoter	NULL
contains	NULL
all	NULL
of	NULL
the	NULL
structural	NULL
features	NULL
of	NULL
a	NULL
typical	NULL
RNA	NULL
pol	NULL
II	NULL
transcription	NULL
tem-plate	NULL
:	NULL
a	NULL
TATA	NULL
box	NULL
~30	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
several	NULL
pol	NULL
II	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
transcripts	NULL
are	NULL
synthesized	NULL
from	NULL
the	NULL
promoter	NULL
.	NULL

Given	NULL
the	NULL
above	NULL
mentioned	NULL
data	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
our	NULL
in	NULL
vitro	NULL
run-off	NULL
transcription	NULL
assays	NULL
were	NULL
supported	NULL
by	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
E6.1	NULL
T-cells	NULL
,	NULL
we	NULL
tested	NULL
our	NULL
in	NULL
vitro	NULL
transcription	NULL
assays	NULL
for	NULL
pol	NULL
II-dependent	NULL
transcription	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
both	NULL
transcription	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
,	NULL
and	NULL
Tax-mediated	NULL
transactivation	NULL
,	NULL
was	NULL
completely	NULL
inhibited	NULL
at	NULL
a	NULL
low	NULL
concentration	NULL
of	NULL
«	NULL
-amanitin	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
versus	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
also	NULL
demonstrated	NULL
the	NULL
relevant	NULL
importance	NULL
of	NULL
the	NULL
TRE1	NULL
region	NULL
for	NULL
Tax-mediated	NULL
transactivation	NULL
by	NULL
using	NULL
DNA	NULL
templates	NULL
containing	NULL
linker-insertion	NULL
substitution	NULL
mutations	NULL
within	NULL
TRE1	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
7-10	NULL
)	NULL
.	NULL

This	NULL
would	NULL
suggest	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
Spl	NULL
or	NULL
Egr-1	NULL
to	NULL
TRE1	NULL
is	NULL
essential	NULL
for	NULL
transactivation	NULL
mediated	NULL
by	NULL
Tax	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicated	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
greatly	NULL
stimulate	NULL
RNA	NULL
synthesis	NULL
in	NULL
vitro	NULL
from	NULL
the	NULL
c-sis/	NULL
PDGF-B	NULL
promoter	NULL
,	NULL
and	NULL
that	NULL
this	NULL
Tax-mediated	NULL
transactivation	NULL
was	NULL
dependent	NULL
not	NULL
only	NULL
on	NULL
RNA	NULL
pol	NULL
II	NULL
,	NULL
but	NULL
also	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
either	NULL
Spl	NULL
or	NULL
Egr-1	NULL
to	NULL
the	NULL
TRE1	NULL
region	NULL
.	NULL

When	NULL
the	NULL
SIS-Lue	NULL
TRE1	NULL
site-directed	NULL
mutants	NULL
were	NULL
analyzed	NULL
for	NULL
Tax-responsiveness	NULL
,	NULL
a	NULL
CCACCC	NULL
motif	NULL
(	NULL
mutants	NULL
YL1-YL3	NULL
)	NULL
and	NULL
a	NULL
GNGNGGGNG	NULL
motif	NULL
(	NULL
mutants	NULL
YL1-YL5	NULL
)	NULL
were	NULL
clearly	NULL
identified	NULL
as	NULL
being	NULL
essential	NULL
for	NULL
conferring	NULL
Tax	NULL
responsiveness	NULL
in	NULL
stimulated	NULL
Jurkat-Tax	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

That	NULL
the	NULL
results	NULL
observed	NULL
in	NULL
this	NULL
experiment	NULL
were	NULL
indeed	NULL
due	NULL
to	NULL
Tax	NULL
and	NULL
not	NULL
a	NULL
result	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
TPA	NULL
and	NULL
ionomycin	NULL
stimulation	NULL
is	NULL
evidenced	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
we	NULL
have	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
analyzed	NULL
a	NULL
series	NULL
of	NULL
linker-scanning	NULL
substitution	NULL
mutants	NULL
within	NULL
the	NULL
TRE1	NULL
region	NULL
using	NULL
unstimulated	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
versus	NULL
unstimulated	NULL
Jurkat-Tax	NULL
cells	NULL
and	NULL
observed	NULL
the	NULL
same	NULL
results	NULL
as	NULL
those	NULL
presented	NULL
in	NULL
this	NULL
article	NULL
.	NULL

It	NULL
should	NULL
also	NULL
be	NULL
noted	NULL
that	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Tax	NULL
results	NULL
in	NULL
a	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

Stimulation	NULL
is	NULL
necessary	NULL
to	NULL
transiently	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
Egr-1	NULL
.	NULL

The	NULL
CCACCC	NULL
motif	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
capable	NULL
of	NULL
binding	NULL
members	NULL
of	NULL
the	NULL
Sp	NULL
family	NULL
of	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
(	NULL
50-53	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
nucleotides	NULL
CCACCC	NULL
also	NULL
comprise	NULL
the	NULL
core	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
DNA	NULL
recognition	NULL
sequence	NULL
for	NULL
the	NULL
Sp	NULL
family	NULL
member	NULL
,	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
(	NULL
57	NULL
)	NULL
.	NULL

This	NULL
same	NULL
CCACCC	NULL
motif	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
gene	NULL
in	NULL
the	NULL
human	NULL
osteosarcoma	NULL
cell	NULL
line	NULL
,	NULL
U2-O8	NULL
,	NULL
involving	NULL
the	NULL
Sp	NULL
family	NULL
members	NULL
,	NULL
Spl	NULL
and	NULL
Sp3	NULL
(	NULL
35	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
GNGNGGGNG	NULL
motif	NULL
has	NULL
also	NULL
been	NULL
previously	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
positive	NULL
cis-acting	NULL
regulatory	NULL
element	NULL
found	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
Eigr-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
immediate-early	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
(	NULL
52	NULL
,	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Previous	NULL
work	NULL
from	NULL
our	NULL
laboratory	NULL
(	NULL
34	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
main	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
TRE1L	NULL
from	NULL
the	NULL
stimulated	NULL
T-cell	NULL
lines	NULL
,	NULL
Jurkat	NULL
E6.1	NULL
and	NULL
Jurkat-Tax	NULL
,	NULL
along	NULL
with	NULL
the	NULL
HTLV-1	NULL
infected	NULL
T-cell	NULL
line	NULL
,	NULL
HUT1O2	NULL
,	NULL
included	NULL
the	NULL
Sp	NULL
family	NULL
members	NULL
Spl	NULL
and	NULL
Sp3	NULL
,	NULL
along	NULL
with	NULL
the	NULL
immediate-early	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
member	NULL
,	NULL
Egr-1	NULL
.	NULL

Fur-thermore	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
since	NULL
the	NULL
TRE1	NULL
region	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
contains	NULL
overlapping	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Sp	NULL
family	NULL
members	NULL
,	NULL
Spl	NULL
and	NULL
Sp3	NULL
,	NULL
and	NULL
the	NULL
immediate-early	NULL
transcription	NULL
factor	NULL
gene	NULL
family	NULL
member	NULL
,	NULL
Egr-1	NULL
,	NULL
these	NULL
factors	NULL
can	NULL
not	NULL
associate	NULL
together	NULL
and	NULL
simultaneously	NULL
bind	NULL
to	NULL
TREL	NULL
.	NULL

27419	NULL
Indeed	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
Spl	NULL
occupies	NULL
this	NULL
element	NULL
and	NULL
is	NULL
displaced	NULL
by	NULL
increasing	NULL
amounts	NULL
of	NULL
Egr-1	NULL
upon	NULL
stimulation	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
CCACCC	NULL
motif	NULL
,	NULL
and	NULL
the	NULL
GNGNGGGNG	NULL
motif	NULL
,	NULL
are	NULL
also	NULL
found	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
two	NULL
genes	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
up-regulated	NULL
and	NULL
transactivated	NULL
by	NULL
Tax	NULL
.	NULL

These	NULL
include	NULL
the	NULL
PTHrP	NULL
gene	NULL
and	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
(	NULL
58	NULL
,	NULL
59	NULL
)	NULL
.	NULL

These	NULL
motifs	NULL
represent	NULL
binding	NULL
sites	NULL
for	NULL
members	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

This	NULL
proves	NULL
to	NULL
be	NULL
interesting	NULL
in	NULL
light	NULL
of	NULL
previous	NULL
experiments	NULL
carried	NULL
out	NULL
to	NULL
investigate	NULL
the	NULL
mecha-nism	NULL
{	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Tax-mediated	NULL
transactivation	NULL
.	NULL

Site-directed	NULL
muta-tional	NULL
analysis	NULL
of	NULL
Tax	NULL
has	NULL
allowed	NULL
for	NULL
an	NULL
approximate	NULL
demarcation	NULL
of	NULL
regions	NULL
within	NULL
the	NULL
Tax	NULL
protein	NULL
itself	NULL
necessary	NULL
for	NULL
transactivation	NULL
(	NULL
41	NULL
,	NULL
63	NULL
)	NULL
.	NULL

These	NULL
analyses	NULL
indicated	NULL
that	NULL
Tax	NULL
transactivation	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
promoters	NULL
occurs	NULL
through	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
cellular	NULL
transcription	NULL
pathways	NULL
:	NULL
1	NULL
)	NULL
the	NULL
CREB/ATF	NULL
family	NULL
and	NULL
2	NULL
)	NULL
the	NULL
NFxB/Rel	NULL
protein	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

It	NULL
now	NULL
appears	NULL
that	NULL
an	NULL
additional	NULL
Tax-mediated	NULL
transactivation	NULL
pathway	NULL
exists	NULL
involving	NULL
members	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

EMSA	NULL
analysis	NULL
showed	NULL
that	NULL
Tax	NULL
dramatically	NULL
enhanced	NULL
the	NULL
site-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
compare	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
Egr-1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
compare	NULL
lane	NULL
6	NULL
versus	NULL
lane	NULL
7	NULL
)	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
the	NULL
TRE1	NULL
site	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
which	NULL
suggested	NULL
that	NULL
Tax	NULL
may	NULL
deregulate	NULL
target	NULL
genes	NULL
by	NULL
enhancing	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
cellular	NULL
transcription	NULL
factors	NULL
that	NULL
recognize	NULL
the	NULL
Tax-responsive	NULL
promoter	NULL
elements	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
Tax	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
,	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
serum	NULL
response	NULL
factor	NULL
,	NULL
Fos-Jun	NULL
,	NULL
and	NULL
the	NULL
NFB	NULL
subunits	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
CCACCC	NULL
and	NULL
GNGNGGGNG	NULL
motifs	NULL
prevented	NULL
the	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
Eigr-1	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
the	NULL
TRE1	NULL
probe	NULL
,	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
9-13	NULL
)	NULL
.	NULL

This	NULL
further	NULL
demonstrated	NULL
the	NULL
importance	NULL
of	NULL
each	NULL
of	NULL
these	NULL
motifs	NULL
for	NULL
conferring	NULL
Tax	NULL
responsiveness	NULL
.	NULL

EMSA	NULL
analysis	NULL
also	NULL
indicated	NULL
that	NULL
Tax	NULL
altered	NULL
the	NULL
mobility	NULL
of	NULL
both	NULL
the	NULL
Sp1l-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
3	NULL
,	NULL
Spl	NULL
C2	NULL
)	NULL
and	NULL
the	NULL
Egr-1-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
7	NULL
,	NULL
Egr-1H4	NULL
C2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
observed	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
for	NULL
Spl	NULL
and	NULL
Egr-1	NULL
(	NULL
mediated	NULL
by	NULL
Tax	NULL
)	NULL
involves	NULL
Tax	NULL
entering	NULL
into	NULL
the	NULL
com-plex	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
ternary	NULL
complexes	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
Spl	NULL
C2	NULL
and	NULL
Egr-1H	NULL
,	NULL
C2	NULL
complexes	NULL
are	NULL
the	NULL
result	NULL
of	NULL
Tax	NULL
increasing	NULL
the	NULL
affinity	NULL
of	NULL
a	NULL
less	NULL
abundant	NULL
complex	NULL
that	NULL
was	NULL
previously	NULL
not	NULL
visible	NULL
in	NULL
the	NULL
Tax-minus	NULL
samples	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
was	NULL
not	NULL
the	NULL
case	NULL
since	NULL
these	NULL
CZ	NULL
complexes	NULL
were	NULL
not	NULL
observed	NULL
upon	NULL
overexposure	NULL
of	NULL
the	NULL
autoradiogram	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
was	NULL
further	NULL
substantiated	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
C-terminal	NULL
13	NULL
amino	NULL
acids	NULL
of	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
completely	NULL
abolish	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
Spl-DNA	NULL
complexes	NULL
Spl	NULL
C1	NULL
and	NULL
Spl	NULL
C2	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Egr-1H	NULL
,	NULL
complexes	NULL
,	NULL
Egr-1H,4	NULL
C1	NULL
and	NULL
Egr-1H4	NULL
C2	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
when	NULL
added	NULL
to	NULL
the	NULL
samples	NULL
containing	NULL
Tax	NULL
.	NULL

This	NULL
is	NULL
indicative	NULL
of	NULL
a	NULL
potentially	NULL
strong	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
,	NULL
in	NULL
which	NULL
binding	NULL
of	NULL
the	NULL
antibody	NULL
to	NULL
Tax	NULL
sterically	NULL
interferes	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
if	NULL
all	NULL
of	NULL
the	NULL
Spl	NULL
and	NULL
Egr-1	NULL
in	NULL
the	NULL
sample	NULL
is	NULL
complexed	NULL
with	NULL
Tax	NULL
,	NULL
then	NULL
,	NULL
no	NULL
binding	NULL
whatsoever	NULL
should	NULL
occur	NULL
.	NULL

Further	NULL
investigation	NULL
of	NULL
the	NULL
physical	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
both	NULL
Spl	NULL
and	NULL
Egr-1	NULL
,	NULL
by	NULL
co-immunoprecipitation	NULL
analysis	NULL
,	NULL
showed	NULL
that	NULL
Tax	NULL
did	NULL
,	NULL
indeed	NULL
,	NULL
stably	NULL
interact	NULL
with	NULL
,	NULL
and	NULL
bind	NULL
to	NULL
,	NULL
both	NULL
purified	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
purified	NULL
Egr-1	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
was	NULL
also	NULL
demonstrated	NULL
by	NULL
co-immunoprecipitation	NULL
analysis	NULL
that	NULL
Tax	NULL
interacts	NULL
with	NULL
both	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27420	NULL
Spl	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
Egr-1	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
represent	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
Tax	NULL
physically	NULL
interacts	NULL
with	NULL
members	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
mutants	NULL
to	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
identified	NULL
two	NULL
Tax	NULL
mutants	NULL
,	NULL
IEXC298	NULL
and	NULL
IEXL320G	NULL
,	NULL
that	NULL
were	NULL
significantly	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Co-immunoprecipitation	NULL
analysis	NULL
also	NULL
revealed	NULL
that	NULL
Tax	NULL
mutant	NULL
IEXC29S8	NULL
was	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
Egr-1	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
compare	NULL
lane	NULL
5	NULL
versus	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
Tax	NULL
mutant	NULL
IEXL320G	NULL
was	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
Egr-1	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
compare	NULL
lane	NULL
5	NULL
versus	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

This	NULL
would	NULL
suggest	NULL
that	NULL
an	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
Egr-1	NULL
is	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
to	NULL
support	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Tax	NULL
mutant	NULL
IEXL320G	NULL
still	NULL
binds	NULL
to	NULL
Egr-1	NULL
,	NULL
but	NULL
fails	NULL
to	NULL
transactivate	NULL
the	NULL
c-sis/PDGF-B	NULL
promoter	NULL
,	NULL
is	NULL
not	NULL
unex-pected	NULL
.	NULL

The	NULL
defect	NULL
in	NULL
IEXL320G	NULL
most	NULL
likely	NULL
results	NULL
from	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
Tax	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
such	NULL
a	NULL
domain	NULL
in	NULL
Tax	NULL
has	NULL
been	NULL
previously	NULL
demonstrated	NULL
(	NULL
65	NULL
)	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
that	NULL
amino	NULL
acid	NULL
residues	NULL
284	NULL
to	NULL
322	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
Tax	NULL
constituted	NULL
a	NULL
functional	NULL
transactivation	NULL
domain	NULL
.	NULL

Similar	NULL
mutations	NULL
of	NULL
the	NULL
same	NULL
amino	NULL
acid	NULL
residues	NULL
in	NULL
Tax	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
defective	NULL
in	NULL
transactivation	NULL
of	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
by	NULL
Tax	NULL
,	NULL
but	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
still	NULL
be	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
CREB	NULL
and	NULL
the	NULL
HTLV-1	NULL
21-bp	NULL
repeats	NULL
to	NULL
assemble	NULL
ternary	NULL
Tax-CREB-DNA	NULL
complexes	NULL
(	NULL
66	NULL
)	NULL
.	NULL

As	NULL
mentioned	NULL
above	NULL
,	NULL
Tax	NULL
is	NULL
able	NULL
to	NULL
increase	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
.	NULL

Perhaps	NULL
the	NULL
best	NULL
characterized	NULL
of	NULL
these	NULL
is	NULL
the	NULL
basic	NULL
region-leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
DNA-binding	NULL
domain	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
protein	NULL
family	NULL
.	NULL

Dimerization	NULL
is	NULL
essential	NULL
for	NULL
bZIP	NULL
proteins	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

Consequently	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
Tax	NULL
stimulated	NULL
the	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
CREB/ATF	NULL
proteins	NULL
both	NULL
quantitatively	NULL
and	NULL
qualitatively	NULL
(	NULL
67-69	NULL
)	NULL
.	NULL

First	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
Tax	NULL
enhanced	NULL
dimer-ization	NULL
,	NULL
thereby	NULL
increasing	NULL
the	NULL
overall	NULL
level	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

Second	NULL
,	NULL
Tax	NULL
altered	NULL
DNA-binding	NULL
site	NULL
selectivity	NULL
.	NULL

Several	NULL
reports	NULL
then	NULL
demonstrated	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
physically	NULL
interact	NULL
with	NULL
several	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
protein	NULL
family	NULL
(	NULL
66	NULL
,	NULL
70	NULL
,	NULL
71	NULL
)	NULL
.	NULL

A	NULL
more	NULL
recent	NULL
report	NULL
demonstrated	NULL
that	NULL
the	NULL
physical	NULL
interaction	NULL
between	NULL
the	NULL
bZIP	NULL
protein	NULL
,	NULL
CREB	NULL
,	NULL
and	NULL
Tax	NULL
to	NULL
form	NULL
a	NULL
Tax-CREB-DNA	NULL
ternary	NULL
complex	NULL
involves	NULL
the	NULL
incorporation	NULL
of	NULL
Tax	NULL
into	NULL
the	NULL
ternary	NULL
complex	NULL
as	NULL
a	NULL
dimer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
form	NULL
a	NULL
dimer	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
its	NULL
interaction	NULL
with	NULL
CREB	NULL
(	NULL
72	NULL
)	NULL
.	NULL

It	NULL
has	NULL
not	NULL
escaped	NULL
our	NULL
attention	NULL
that	NULL
Tax	NULL
's	NULL
interactions	NULL
with	NULL
bZIP	NULL
proteins	NULL
deals	NULL
exclusively	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
both	NULL
Tax	NULL
,	NULL
and	NULL
the	NULL
bZIP	NULL
protein	NULL
,	NULL
to	NULL
dimerize	NULL
.	NULL

When	NULL
one	NULL
considers	NULL
the	NULL
situation	NULL
involving	NULL
the	NULL
interaction	NULL
(	NULL
s	NULL
)	NULL
between	NULL
Tax	NULL
and	NULL
members	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
do	NULL
not	NULL
normally	NULL
dimerize	NULL
prior	NULL
to	NULL
DNA	NULL
binding	NULL
,	NULL
or	NULL
,	NULL
that	NULL
dimerization	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
their	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
immediately	NULL
becomes	NULL
apparent	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
article	NULL
support	NULL
the	NULL
possibility	NULL
of	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
additional	NULL
,	NULL
as	NULL
yet	NULL
uncharacterized	NULL
,	NULL
pathway	NULL
of	NULL
transactivation	NULL
by	NULL
Tax	NULL
involving	NULL
members	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Several	NULL
questions	NULL
as	NULL
to	NULL
the	NULL
exact	NULL
nature	NULL
of	NULL
this	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
zinc	NULL
finger	NULL
family	NULL
transcription	NULL
factors	NULL
still	NULL
remain	NULL
to	NULL
be	NULL
answered	NULL
.	NULL

First	NULL
,	NULL
and	NULL
foremost	NULL
,	NULL
the	NULL
issue	NULL
of	NULL
whether	NULL
Tax	NULL
dimerization	NULL
is	NULL
necessary	NULL
for	NULL
engaging	NULL
in	NULL
interactions	NULL
with	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
will	NULL
have	NULL
to	NULL
be	NULL
addressed	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
more	NULL
detailed	NULL
analysis	NULL
of	NULL
the	NULL
domains	NULL
within	NULL
Tax	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
interacting	NULL
with	NULL
the	NULL
various	NULL
zinc	NULL
finger	NULL
family	NULL
transcription	NULL
factor	NULL
HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
members	NULL
will	NULL
need	NULL
to	NULL
be	NULL
undertaken	NULL
.	NULL

Experiments	NULL
are	NULL
currently	NULL
underway	NULL
to	NULL
address	NULL
these	NULL
and	NULL
other	NULL
aspects	NULL
of	NULL
the	NULL
Tax-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
c-sis/PDGF-B	NULL
proto-oncogene	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
J.	NULL
Milbrandt	NULL
for	NULL
the	NULL
NGFI-A/Eigr-1	NULL
expression	NULL
plasmids	NULL
pJDM1731	NULL
and	NULL
pJDM948	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
for	NULL
the	NULL
TaxH	NULL
,	NULL
expression	NULL
plasmid	NULL
and	NULL
the	NULL
aTaxC	NULL
antisera	NULL
,	NULL
and	NULL
O.	NULL
J.	NULL
Semmes	NULL
for	NULL
the	NULL
Tax	NULL
expression	NULL
plasmids	NULL
IEX	NULL
,	NULL
IEXS10A	NULL
,	NULL
IEXC29S	NULL
,	NULL
IEXHA43Q	NULL
,	NULL
IEXS258A	NULL
,	NULL
and	NULL
IEXL820G	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
D.	NULL
C.	NULL
Dean	NULL
,	NULL
T.	NULL
J.	NULL
Ley	NULL
,	NULL
J.	NULL
E.	NULL
Majors	NULL
,	NULL
and	NULL
D.	NULL
B.	NULL
Wilson	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
.	NULL

Ratner	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Poiesz	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Medicine	NULL
67	NULL
,	NULL
401-422	NULL
2	NULL
.	NULL

Bangham	NULL
,	NULL
C.	NULL
R.	NULL
M.	NULL
,	NULL
Daenke	NULL
,	NULL
S.	NULL
,	NULL
Phillips	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Cruickshank	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Bell	NULL
,	NULL
J.	NULL
I	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
4179-4184	NULL
3	NULL
.	NULL

Bhagavati	NULL
,	NULL
S.	NULL
,	NULL
Ehrlich	NULL
,	NULL
G.	NULL
,	NULL
Kula	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Kwok	NULL
,	NULL
S.	NULL
,	NULL
Sninsky	NULL
,	NULL
J.	NULL
,	NULL
Udani	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Poiesz	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

818	NULL
,	NULL
1141-1147	NULL
4	NULL
.	NULL

Brady	NULL
,	NULL
J.	NULL
,	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
Duvall	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Khoury	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

61	NULL
,	NULL
2175-2181	NULL
5	NULL
.	NULL

Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Paskalis	NULL
,	NULL
H.	NULL
,	NULL
Kleinman-Ewing	NULL
,	NULL
C.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Pavlakis	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
229	NULL
,	NULL
675-679	NULL
6	NULL
.	NULL

Paskalis	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
and	NULL
Pavlakis	NULL
,	NULL
G.	NULL
N.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
6558-6562	NULL
7	NULL
.	NULL

Seiki	NULL
,	NULL
M.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Hidaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
7124-7128	NULL
8	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1875-1885	NULL
9	NULL
.	NULL

Li	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Siekevitz	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6490-6500	NULL
10	NULL
.	NULL

Ratner	NULL
,	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
4101-4115	NULL
11	NULL
.	NULL

Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Chen	NULL
,	NULL
I.	NULL
S.	NULL
,	NULL
and	NULL
Wachsman	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
1457-1461	NULL
12	NULL
.	NULL

Altman	NULL
,	NULL
R.	NULL
,	NULL
Harrich	NULL
,	NULL
D.	NULL
,	NULL
Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
1339-1346	NULL
13	NULL
.	NULL

Armstrong	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Henbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Giebler	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
7808-7307	NULL
14	NULL
.	NULL

Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Kubik	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Uittenbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
Utaisincharoen	NULL
,	NULL
P.	NULL
,	NULL
Matthews	NULL
,	NULL
M-A	NULL
.	NULL

H	NULL
,	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Hoeffler	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
21225-21231	NULL
15	NULL
.	NULL

Seeler	NULL
,	NULL
J-S.	NULL
,	NULL
Muchardt	NULL
,	NULL
C.	NULL
,	NULL
Podar	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Virology	NULL
196	NULL
,	NULL
442-450	NULL
16	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
L	NULL
,	NULL
Toita	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yoshida	NULL
,	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
610-614	NULL
17	NULL
.	NULL

Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
395-399	NULL
18	NULL
.	NULL

Yin	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Paulssen	NULL
,	NULL
E.	NULL
,	NULL
Seeler	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
a	NULL
6209-6218	NULL
19	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Giam	NULL
,	NULL
C.	NULL
Z	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
11445-11449	NULL
20	NULL
.	NULL

Zhao	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Giam	NULL
,	NULL
C.	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7070-7074	NULL
21	NULL
.	NULL

Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
Widen	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
IV	NULL
,	NULL
and	NULL
Wilson	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1082-1084	NULL
22	NULL
.	NULL

Uittenbogaard	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Armstrong	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Chiaramello	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
22466-22469	NULL
23	NULL
.	NULL

Doolittle	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Hunkapiller	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Hood	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Devare	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Robbins	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Aaronson	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Antoniades	NULL
,	NULL
H.	NULL
N.	NULL
(	NULL
1983	NULL
)	NULL
Science	NULL
221	NULL
,	NULL
275-277	NULL
24	NULL
.	NULL

Waterfield	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Scrace	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
Whittle	NULL
,	NULL
N.	NULL
,	NULL
Stroobant	NULL
,	NULL
P.	NULL
,	NULL
Johnsson	NULL
,	NULL
A.	NULL
,	NULL
Wasteson	NULL
,	NULL
A.	NULL
,	NULL
Westermark	NULL
,	NULL
B.	NULL
,	NULL
Heldin	NULL
,	NULL
C-H.	NULL
,	NULL
Huang	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Devel	NULL
,	NULL
T.	NULL
F.	NULL
(	NULL
1983	NULL
)	NULL
Nature	NULL
804	NULL
,	NULL
35-39	NULL
25	NULL
.	NULL

Pantazis	NULL
,	NULL
P.	NULL
,	NULL
Sariban	NULL
,	NULL
E.	NULL
,	NULL
Bohan	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Antoniades	NULL
,	NULL
H.	NULL
N.	NULL
,	NULL
and	NULL
Kalyanaraman	NULL
,	NULL
V.	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Oncogene	NULL
1	NULL
,	NULL
285-289	NULL
26	NULL
.	NULL

Clarke	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Westin	NULL
,	NULL
E.	NULL
,	NULL
Schmidt	NULL
,	NULL
D.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Ratner	NULL
,	NULL
L.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Reitz	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
808	NULL
,	NULL
464-467	NULL
27	NULL
.	NULL

Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Ratner	NULL
,	NULL
L.	NULL
,	NULL
Clarke	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Westin	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Reitz	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1984	NULL
)	NULL
Science	NULL
225	NULL
,	NULL
636-639	NULL
28	NULL
.	NULL

Dirks	NULL
,	NULL
R.	NULL
P.	NULL
H.	NULL
,	NULL
Jansen	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
van	NULL
Gerven	NULL
,	NULL
B.	NULL
,	NULL
Onnekink	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Bloemers	NULL
,	NULL
H.	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

28	NULL
,	NULL
1119-1126	NULL
29	NULL
.	NULL

Ross	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Vogel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
Cell	NULL
14	NULL
,	NULL
203-210	NULL
30	NULL
.	NULL

Johnsson	NULL
,	NULL
A.	NULL
,	NULL
Heldin	NULL
,	NULL
C-H.	NULL
,	NULL
Westermark	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Wasteson	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

104	NULL
,	NULL
66-74	NULL
31	NULL
.	NULL

Hart	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
and	NULL
Bowen-Pope	NULL
,	NULL
D.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

94	NULL
,	NULL
538-578	NULL
82	NULL
.	NULL

Clarke	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Westin	NULL
,	NULL
E.	NULL
,	NULL
Schmidt	NULL
,	NULL
D.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Ratner	NULL
,	NULL
L.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Reitz	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Jr.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
808	NULL
,	NULL
464-467	NULL
33	NULL
.	NULL

Goustin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Galanopoulos	NULL
,	NULL
T.	NULL
,	NULL
Kalyanaraman	NULL
,	NULL
V.	NULL
S.	NULL
,	NULL
and	NULL
Pantazis	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Growth	NULL
Factors	NULL
2	NULL
,	NULL
189-195	NULL
34	NULL
.	NULL

Trejo	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Fahl	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Ratner	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
14584-14590	NULL
35	NULL
.	NULL

Liang	NULL
,	NULL
Y.	NULL
,	NULL
Robinson	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Dennig	NULL
,	NULL
J.	NULL
,	NULL
Suske	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Fahl	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
11792-11797	NULL
36	NULL
.	NULL

Liang	NULL
,	NULL
Y.	NULL
,	NULL
Robinson	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Kujoth	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
and	NULL
Fahl	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Oncogene	NULL
12	NULL
,	NULL
1-9	NULL
37	NULL
.	NULL

Khachigian	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Linder	NULL
,	NULL
V.	NULL
,	NULL
Williams	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
271	NULL
,	NULL
1427-1431	NULL
38	NULL
.	NULL

Jin	NULL
,	NULL
H.-M.	NULL
,	NULL
Robinson	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Liang	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Fahl	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
28648-28654	NULL
39	NULL
.	NULL

Jin	NULL
,	NULL
H.-A	NULL
.	NULL

,	NULL
Brady	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Fahl	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
7563-7567	NULL
40	NULL
.	NULL

Wano	NULL
,	NULL
Y.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
,	NULL
Hosking	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
9733-9737	NULL
41	NULL
.	NULL

Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
7183-7192	NULL
42	NULL
.	NULL

Swirnoff	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
Milbrandt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2275-2287	NULL
43	NULL
.	NULL

Zhao	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
and	NULL
Giam	NULL
,	NULL
C.-H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
Interacts	NULL
with	NULL
Sp1	NULL
and	NULL
Egr-1	NULL
57	NULL
.	NULL

58	NULL
.	NULL

11445-11449	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
C-Y	NULL
.	NULL

,	NULL
Petryniak	NULL
,	NULL
B.	NULL
,	NULL
Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
5890-5897	NULL
Langton	NULL
,	NULL
B.	NULL
C.	NULL
,	NULL
Sliwkowski	NULL
,	NULL
M.	NULL
,	NULL
Tran	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
Knapp	NULL
,	NULL
S.	NULL
,	NULL
Keitelman	NULL
,	NULL
E.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
,	NULL
Wallingford	NULL
,	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
H.-L.	NULL
,	NULL
Ralston	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Brandis	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Coates	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Med	NULL
.	NULL

Virol	NULL
.	NULL

8	NULL
,	NULL
295	NULL
Jacob	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Sajdel	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
and	NULL
Munro	NULL
,	NULL
H.	NULL
N.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
225	NULL
,	NULL
60-62	NULL
Kedinger	NULL
,	NULL
C.	NULL
,	NULL
Gniazdowski	NULL
,	NULL
M.	NULL
,	NULL
Mandel	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Gissinger	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1970	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

88	NULL
,	NULL
165-171	NULL
Lindell	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Weinberg	NULL
,	NULL
F.	NULL
,	NULL
Morris	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1970	NULL
)	NULL
Science	NULL
170	NULL
,	NULL
447-449	NULL
Cochet-Meilhac	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1974	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
8538	NULL
,	NULL
160-184	NULL
Yu	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
Motamed	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
J.	NULL
,	NULL
Bailey	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
and	NULL
Shen	NULL
,	NULL
C.-K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
8907-8915	NULL
Kudo	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Fukuda	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

228	NULL
,	NULL
319-327	NULL
Skerka	NULL
,	NULL
C.	NULL
,	NULL
Decker	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
22500-22506	NULL
Dittmer	NULL
,	NULL
J.	NULL
,	NULL
Gegonne	NULL
,	NULL
A.	NULL
,	NULL
Gitlin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
21428-21434	NULL
Gashler	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

50	NULL
,	NULL
191-224	NULL
Ebert	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Balt	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Hunter	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Gashler	NULL
,	NULL
A.	NULL
,	NULL
Sukhatme	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Wong	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
20885-20898	NULL
Kramer	NULL
,	NULL
B.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Wiegmann	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Kronke	NULL
,	NULL
M.	NULL
J.	NULL
Inflammation	NULL
45	NULL
,	NULL
183-192	NULL
(	NULL
1995	NULL
)	NULL
59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

TL	NULL
.	NULL

72	NULL
.	NULL

27421	NULL
Letovsky	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
2639-2653	NULL
Dittmer	NULL
,	NULL
J.	NULL
,	NULL
Gitlin	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Reid	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
6087-6095	NULL
Connor	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Oxman	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Marriott	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Virology	NULL
195	NULL
,	NULL
569-577	NULL
Marriott	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Boros	NULL
,	NULL
L.	NULL
,	NULL
Duvall	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
4152-4160	NULL
Piras	NULL
,	NULL
G.	NULL
,	NULL
Kashanchi	NULL
,	NULL
F.	NULL
,	NULL
Radonovich	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Duvall	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

68	NULL
,	NULL
6170-6179	NULL
Duvall	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Kashanchi	NULL
,	NULL
F.	NULL
,	NULL
Cvekl	NULL
,	NULL
A.	NULL
,	NULL
Radonovich	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Piras	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Brady	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
5077-5086	NULL
Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1975-1885	NULL
Matthews	NULL
,	NULL
M-A	NULL
.	NULL

,	NULL
Markowitz	NULL
,	NULL
R-B	NULL
.	NULL

,	NULL
and	NULL
Dynan	NULL
,	NULL
W.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1986-1996	NULL
Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
1827-1833	NULL
Adya	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Giam	NULL
,	NULL
C.-Z	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
1834-1841	NULL
Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
395-399	NULL
Perini	NULL
,	NULL
G.	NULL
,	NULL
Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Green	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
876	NULL
,	NULL
602-605	NULL
Baranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Palmer	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Hamm	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Giebler	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Brauweiler	NULL
,	NULL
A.	NULL
,	NULL
Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Schepartz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nature	NULL
376	NULL
,	NULL
606-608	NULL
Goren	NULL
,	NULL
I.	NULL
,	NULL
Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
and	NULL
Moelling	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
5806-5811	NULL
Yin	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Paulssen	NULL
,	NULL
E.	NULL
,	NULL
Seeler	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
6209-6218	NULL
Tie	NULL
,	NULL
F.	NULL
,	NULL
Adya	NULL
,	NULL
N.	NULL
,	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Giam	NULL
,	NULL
C.-Z	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

70	NULL
,	NULL
8368-8374	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
The	NULL
Tax	NULL
Protein	NULL
of	NULL
Human	NULL
T-cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
Mediates	NULL
the	NULL
Transactivation	NULL
of	NULL
the	NULL
c-	NULL
sis/Platelet-derived	NULL
Growth	NULL
Factor-B	NULL
Promoter	NULL
through	NULL
Interactions	NULL
with	NULL
the	NULL
Zinc	NULL
Finger	NULL
Transcription	NULL
Factors	NULL
Spl	NULL
and	NULL
NGFI-A/Egr-1	NULL
Samuel	NULL
R.	NULL
Trejo	NULL
,	NULL
William	NULL
E.	NULL
Fahl	NULL
and	NULL
Lee	NULL
Ratner	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:27411-27421.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.43.27411	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/43/27411	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
72	NULL
references	NULL
,	NULL
46	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

